Presbycusis

H8_HL_PRESBY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H91.1 Hospital discharge: ICD-9 — 3880 Hospital discharge: excluded ICD-9 — 2880X Cause of death: ICD-10 — H91.1 Cause of death: ICD-9 — 3880 Cause of death: excluded ICD-9 — 2880X 2 out of 7 registries used, show all original rules.	7744
4. Check minimum number of events None	7744
5. Include endpoints None	7744
6. Filter based on genotype QC (FinnGen only)	6922

Control definitions (FinnGen only)

Control exclude: H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H91
Name in latin: Presbyacusis

NAME	H8_HL_PRESBY
CONTROL_EXCLUDE	H8_OTHEREAR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H911
HD_ICD_9	3880
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	2880X
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H911
COD_ICD_9	3880
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	2880X
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Presbycusis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	64425	38004	26033
Only index persons	55412	33250	22162
Unadjusted period prevalence (%)
Whole population	0.94	1.09	0.73
Only index persons	1.07	1.22	0.85
Median age at first event (years)
Whole population	80.01	81.05	78.51
Only index persons	79.56	80.63	77.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6922	3325	3597
Unadjusted period prevalence (%)	1.42	1.18	1.65
Median age at first event (years)	77.24	77.51	76.99

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7128: Matched controls
70382

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H93.1

ICD-10 Finland

Tinnitus

8.4

317.7

429

534

H81

ICPC

Excessive ear wax

3.1

307.7

2151

8562

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

70.1

307.7

1212

205

H84

ICPC

Presbyacusis

7.1

307.7

844

1301

DFF00

NOMESCO Finland

Pure tone audiometry

19.7

307.7

1774

1165

DFF15

NOMESCO Finland

Speech audiometry

17.3

307.7

906

587

Z3229

NOMESCO Finland

Other healthcare associate professional

4.5

307.7

1151

2863

R5120

NOMESCO Finland

Preparation of an aid

12.8

307.7

687

583

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

115.6

307.7

3420

557

H91.9

ICD-10 Finland

Hearing loss, unspecified

9.9

307.7

708

778

R5140

NOMESCO Finland

Monitoring the use of the aid

4.6

307.7

1134

2783

SPAT1043

SPAT

Audiometry

7.5

307.7

1688

2800

R4135

NOMESCO Finland

Rehabilitation for hearing problems

26.9

307.7

265

101

DAX08

NOMESCO Finland

Fitting of hearing aid

36.2

307.7

1257

414

H02

ICPC

Hearing complaint

7.1

307.7

2540

5110

Z01.1

ICD-10 Finland

Examination of ears and hearing

13.0

307.7

2509

2826

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

99.0

307.7

195

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

25.9

307.7

873

377

Z97.4

ICD-10 Finland

Presence of external hearing-aid

27.8

307.7

1436

633

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

8.3

307.7

472

596

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

5.1

307.7

1569

3681

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

53.8

307.7

232

H91.1

ICD-10 Finland

Presbycusis

4503599627370496.0

307.7

7122

1541

UDC00

NOMESCO Finland

Ear microscopy

12.2

307.7

1178

1122

H13

ICPC

Plugged feeling ear

3.2

307.7

2278

8969

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

3.6

307.7

2476

9110

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

24.1

307.7

1889

1036

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

22.7

307.7

572

270

TDA90

NOMESCO Finland

Removal wax from ear

14.5

285.0

261

184

H29

ICPC

Ear symptom/complaint other

3.3

284.0

1240

4188

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.0

258.2

816

2219

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

36.7

243.7

153

DFX03

NOMESCO Finland

Review, maintenance and user education for hearing aid

33.9

214.9

138

Z97.8

ICD-10 Finland

Presence of other specified devices

37.6

192.4

120

TDA90, ,

SPAT

3.5

187.5

715

2191

A98

ICPC

Health maint/preventive medicine

2.8

182.8

6225

50214

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

39.7

174.0

107

N02BE01

ATC

paracetamol; systemic, rectal

2.8

166.2

6340

52246

R5599

NOMESCO Finland

Other rehabilitation service

4.9

152.5

345

718

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

7.0

144.7

225

327

N07CA01

ATC

betahistine; oral

3.0

142.9

672

2326

SPAT1310

SPAT

Counselling related to known health issue

1.9

133.1

2293

13883

RK520, ,

NOMESCO Finland

27.3

130.9

R1260

NOMESCO Finland

Evaluation of communicative skills

5.5

122.9

242

445

H90.5

ICD-10 Finland

Sensorineural hearing loss, unspecified

10.4

120.2

135

131

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

119.2

3473

24504

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.8

118.4

3884

28341

H61.2

ICD-10 Finland

Impacted cerumen

2.8

115.0

635

2390

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

112.7

2999

20504

SPAT1263

SPAT

Sampling

1.8

108.8

2948

20199

H28

ICPC

Limited function/disability (H)

7.6

108.0

154

203

ZXA10

NOMESCO Finland

Bilateral

1.9

106.7

1695

9870

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

104.5

3419

24598

SPAT1260

SPAT

Consultation of another employee

2.0

104.4

1386

7586

J01DB01

ATC

cefalexin; oral

1.8

103.5

5366

43849

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

96.2

4078

31162

SPAT1312

SPAT

General health counselling

1.8

95.8

2006

12658

M79.6

ICD-10 Finland

Pain in limb

1.7

95.3

2778

19223

A02BC02

ATC

pantoprazole; systemic

1.7

95.3

4784

38193

S18

ICPC

Laceration/cut

1.7

95.0

3329

24174

SPAT1325

SPAT

Vaccination

1.7

91.9

2776

19340

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

18.7

91.4

H90.0

ICD-10 Finland

Conductive hearing loss, bilateral

19.7

91.0

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

26.1

90.3

SPAT1053

SPAT

Memory test

1.8

88.2

1699

10417

SPAT1153

SPAT

Removal of sutures

1.7

88.0

2251

14958

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

219.9

85.1

SPAT1301

SPAT

No procedures

1.7

84.5

2445

16750

H04

ICPC

Ear discharge

3.4

83.4

318

965

R42

ICD-10 Finland

Dizziness and giddiness

1.7

83.2

2015

13155

-1, ,

NOMESCO Finland

1.8

82.9

1683

10452

L03

ICPC

Low back symptom/complaint

1.8

82.8

1765

11118

H01

ICPC

Ear pain/earache

2.4

81.8

632

2781

R01AD09

ATC

mometasone; nasal

1.7

81.3

2239

15107

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

81.1

1901

12283

R05

ICPC

Cough

1.8

80.1

1565

9599

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

79.1

2519

17611

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

79.0

2068

13747

-44

ICPC

Preventive immunization/medic

2.1

78.3

824

4110

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

78.3

1509

9210

P20

ICPC

Memory disturbance

1.7

75.0

1693

10790

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

74.5

3624

27890

SPAT1097

SPAT

Recording of ECG

1.8

74.5

1232

7168

AA1AD

NOMESCO Finland

CT of head and brain

1.6

74.5

2543

18018

DFX03, ,

SPAT

19.2

73.6

R01AD12

ATC

fluticasone furoate; nasal

1.8

73.3

1256

7384

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.6

72.5

3033

22500

J01CA04

ATC

amoxicillin; systemic

1.6

71.7

4940

41039

H90.8

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unspecified

17.3

71.2

H92.0

ICD-10 Finland

Otalgia

3.2

70.9

287

903

N40

ICD-10 Finland

Hyperplasia of prostate

1.6

69.7

2072

14142

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

68.7

3203

24252

L08

ICPC

Shoulder symptom/complaint

1.7

67.9

1436

8955

M54.5

ICD-10 Finland

Low back pain

1.6

65.4

2081

14394

G04BD12

ATC

mirabegron; oral

1.8

64.8

1092

6367

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

63.1

1591

10372

ZXC50

NOMESCO Finland

Cryotherapy

2.6

61.9

379

1493

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

61.9

1032

5990

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

61.7

929

5223

RK320, ,

NOMESCO Finland

6.1

61.4

107

175

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

60.9

2096

14719

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

60.7

2008

13968

L13

ICPC

Hip symptom/complaint

1.7

60.1

1438

9234

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

60.1

2132

15066

N17

ICPC

Vertigo/dizziness

1.8

59.9

1097

6543

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.5

59.9

382

1535

Z71.8

ICD-10 Finland

Other specified counselling

1.6

59.5

1960

13611

SPAT1041

SPAT

Comprehensive hearing test

6.2

59.2

102

165

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

59.1

469

2080

M01AH05

ATC

etoricoxib; oral

1.5

58.6

3146

24263

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

57.7

3562

28231

RK110, ,

NOMESCO Finland

6.1

57.7

101

166

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

57.6

5033

42843

L17

ICPC

Foot/toe symptom/complaint

1.6

57.6

2003

14062

SPAT1131

SPAT

Colonoscopy

2.8

57.4

299

1085

G04CA02

ATC

tamsulosin; oral

1.5

57.2

2188

15688

ZXE00

NOMESCO Finland

One hour or less

1.5

56.8

2641

19733

XKD00

NOMESCO Finland

Uroflowmetry

1.7

56.6

1398

9033

H26.4

ICD-10 Finland

After-cataract

1.7

56.1

1189

7376

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

54.6

2283

16646

H91

ICD-10 Finland

Other hearing loss

6.3

54.4

146

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.5

54.3

359

1467

G47.3

ICD-10 Finland

Sleep apnoea

1.7

54.1

1094

6694

H90.2

ICD-10 Finland

Conductive hearing loss, unspecified

19.9

54.0

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

53.9

1735

11937

R06.0

ICD-10 Finland

Dyspnoea

1.5

53.4

2127

15337

L01

ICPC

Neck symptom/complaint

1.8

52.7

877

5070

R4110, ,

SPAT

1.8

52.7

859

4936

H60.8

ICD-10 Finland

Other otitis externa

3.5

52.4

181

515

R02

ICPC

Shortness of breath/dyspnoea

1.7

52.0

1076

6621

SPAT1262

SPAT

Handing over of treatment supplies

1.6

51.2

1328

8663

L15

ICPC

Knee symptom/complaint

1.6

50.9

1497

10066

H81.0

ICD-10 Finland

Ménière disease

3.9

50.8

154

401

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

50.3

957

5748

RK120, ,

NOMESCO Finland

13.2

50.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

48.7

1872

13341

R01AD58

ATC

fluticasone, combinations; nasal

1.8

48.7

838

4888

R03AC02

ATC

salbutamol; inhalant

1.4

48.5

3132

24727

H80.9

ICD-10 Finland

Otosclerosis, unspecified

9.6

48.4

WZC00, ,

SPAT

1.8

48.1

824

4797

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.9

47.5

713

3987

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

47.1

1211

7866

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

46.9

2151

15873

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

46.1

1364

9155

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.8

45.6

P06

ICPC

Sleep disturbance

1.9

45.2

603

3245

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

45.2

2112

15622

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

4.2

44.9

119

281

D07AC01

ATC

betamethasone; topical

1.5

44.9

2257

16929

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

44.8

2035

14960

L57.0

ICD-10 Finland

Actinic keratosis

1.6

44.6

1070

6821

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

44.4

2554

19637

U04

ICPC

Incontinence urine

1.9

44.3

620

3389

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

44.1

1543

10744

K02.1

ICD-10 Finland

Caries of dentine

1.4

43.8

2691

20928

Z01.2

ICD-10 Finland

Dental examination

1.5

43.5

2087

15489

SPAT1377

SPAT

Polysomnography

3.1

43.4

182

585

C10AA05

ATC

atorvastatin; oral

1.4

43.4

3166

25376

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

43.2

2652

20608

C07AB07

ATC

bisoprolol; oral

1.4

42.9

4110

34517

M25.5

ICD-10 Finland

Pain in joint

1.5

42.7

1575

11077

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

2.6

42.4

244

932

U02

ICPC

Urinary frequency/urgency

1.6

42.2

1035

6628

H91.8

ICD-10 Finland

Other specified hearing loss

5.8

41.8

133

SFA10

NOMESCO Finland

One-surface restoration

1.4

41.8

2587

20099

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.9

41.7

540

2876

R53

ICD-10 Finland

Malaise and fatigue

1.5

41.6

1899

13937

R05

ICD-10 Finland

Cough

1.6

41.6

1262

8500

L12

ICPC

Hand/finger symptom/complaint

1.7

41.5

958

6039

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

41.2

2689

21073

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

41.1

1675

12013

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

5.4

40.9

150

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.5

40.8

1471

10285

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

8.0

40.7

A02BC05

ATC

esomeprazole; systemic

1.4

40.4

2473

19143

WW200, ,

SPAT

1.5

40.4

1642

11766

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

40.0

2597

20302

SFA20

NOMESCO Finland

Two-surface restoration

1.4

40.0

2569

20048

HAHOM, ,

NOMESCO Finland

5.2

39.9

157

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.4

39.9

278

1163

E0000UV, ,

ATC

1.4

39.9

2525

19653

-69

ICPC

Other reason for encounter NEC

2.3

39.8

326

1462

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

39.7

2088

15713

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

39.6

2457

19048

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

5.4

39.5

144

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

39.4

921

5819

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.0

39.4

445

2260

KMAK, ,

NOMESCO Finland

1.4

39.3

2348

18074

D82

ICPC

Teeth/gum disease

1.5

39.3

1512

10705

A28

ICPC

Limited function/disability NOS

1.4

39.2

1978

14763

B01AF02

ATC

apixaban; oral

1.5

39.2

1302

8933

UKC02

NOMESCO Finland

Cystoscopy

1.5

39.2

1405

9799

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

39.0

5057

44379

L28

ICPC

Limited function/disability (L)

1.5

38.9

1770

12953

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

38.8

712

4217

M03BX02

ATC

tizanidine; oral

1.4

38.7

2912

23313

WX723

NOMESCO Finland

CPAP therapy

2.8

38.6

201

729

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

38.2

1361

9472

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.7

38.1

863

5408

R01AD08

ATC

fluticasone; nasal

1.5

37.6

1296

8956

J01AA02

ATC

doxycycline; systemic

1.4

37.5

4911

42994

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

37.2

1770

13046

OAB50, ,

SPAT

1.9

37.1

528

2897

RK420, ,

NOMESCO Finland

99.3

36.5

Z02.4

ICD-10 Finland

Examination for driving licence

1.4

36.2

2160

16567

Z00.0

ICD-10 Finland

General medical examination

1.5

36.1

1257

8698

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

35.7

1180

8070

HMAK, ,

NOMESCO Finland

1.8

35.7

539

3011

H83.3

ICD-10 Finland

Noise effects on inner ear

6.0

35.5

105

S21

ICPC

Skin texture symptom/complaint

1.6

35.4

1013

6708

WX780

NOMESCO Finland

Remote monitoring CPAP

2.7

35.2

199

754

G04CA01

ATC

alfuzosin; oral

1.6

34.9

941

6144

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.5

34.8

221

886

J01FA10

ATC

azithromycin; systemic

1.4

34.8

2602

20699

R74

ICPC

Upper respiratory infection acute

1.6

34.7

1063

7145

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.6

34.6

797

5008

R21

ICPC

Throat symptom/complaint

1.7

34.4

736

4538

S82

ICPC

Naevus/mole

1.7

34.2

769

4802

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

34.2

1365

9701

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.4

33.6

186

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

33.5

320

1526

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

33.5

632

3767

G04CB01

ATC

finasteride; oral

1.5

33.1

1084

7388

SPAT1211

SPAT

Application of soft bandage

1.7

32.9

613

3639

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.3

32.9

193

S29

ICPC

Skin symptom/complaint other

1.5

32.8

1296

9183

N30.0

ICD-10 Finland

Acute cystitis

1.5

32.8

1233

8650

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

32.1

1979

15202

M01AX05

ATC

glucosamine; oral

1.4

32.0

1608

11915

R51.80

ICD-10 Finland

Headache

1.7

32.0

699

4329

C10AA01

ATC

simvastatin; oral

1.3

31.8

3650

30869

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

31.6

1191

8351

WX402

NOMESCO Finland

General anaesthesia

1.5

31.5

1072

7360

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

31.4

656

4015

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

31.2

1888

14442

H02AB06

ATC

prednisolone; systemic

1.3

31.2

3081

25456

K80

ICPC

Cardiac arrhythmia NOS

1.7

31.0

597

3575

M01AB05

ATC

diclofenac; systemic, rectal

1.3

31.0

3613

30579

J01MA02

ATC

ciprofloxacin; systemic

1.3

30.9

2768

22527

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

30.9

805

5206

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

30.7

848

5557

RD211, ,

NOMESCO Finland

2.1

30.7

295

1411

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.7

30.5

165

611

SFA30

NOMESCO Finland

Three-surface restoration

1.4

30.5

1911

14695

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

30.4

1881

14427

N03AX12

ATC

[U] gabapentin; oral

1.5

30.4

945

6359

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

30.2

361

1868

A11

ICPC

Chest pain NOS

1.7

30.1

619

3771

-51

ICPC

I&d/flush/aspiration

3.3

30.0

112

336

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

30.0

778

5023

G44.2

ICD-10 Finland

Tension-type headache

1.7

30.0

627

3837

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

29.8

2093

16381

R06AE07

ATC

cetirizine; oral

1.4

29.7

2227

17607

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

29.7

939

6341

DFF05, ,

SPAT

3.8

29.6

231

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

29.6

749

4808

A02BC01

ATC

omeprazole; systemic

1.4

29.5

1968

15272

L16

ICPC

Ankle symptom/complaint

1.7

29.4

618

3787

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

29.3

402

2177

SDA03

NOMESCO Finland

Periodontal treatment

1.4

29.3

1647

12419

A97

ICPC

No disease

1.5

29.2

1251

8979

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

29.2

570

3426

XCH00

NOMESCO Finland

Eye pressure measurement

1.9

29.0

391

2105

RK290, ,

NOMESCO Finland

9.6

29.0

A04

ICPC

Weakness/tiredness general

1.5

28.9

1178

8374

207

Kela drug reimbursment

Chronic arrhythmias

1.4

28.9

1591

11950

A02BC03

ATC

lansoprazole; oral

1.4

28.9

1934

15007

DFF00, ,

SPAT

3.5

28.8

282

D01BA02

ATC

terbinafine; oral

1.4

28.7

1473

10926

H60.3

ICD-10 Finland

Other infective otitis externa

3.1

28.6

119

382

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

28.4

1061

7415

OAB42, ,

SPAT

1.6

28.3

624

3870

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

28.1

2386

19184

C08CA01

ATC

amlodipine; oral

1.3

28.1

3079

25686

-31

ICPC

Medical examin/health eval partial

1.8

28.1

486

2823

C09CA01

ATC

losartan; oral

1.4

28.1

1875

14528

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

28.1

354

1865

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

27.8

1430

10607

K30

ICD-10 Finland

Functional dyspepsia

1.7

27.7

596

3671

R01AD01

ATC

beclometasone; nasal

1.6

27.7

746

4856

N02BF01

ATC

gabapentin; oral

1.7

27.6

545

3285

UJF32

NOMESCO Finland

Coloscopy

1.4

27.5

1787

13776

R06AX27

ATC

desloratadine; oral

1.5

27.2

1033

7238

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.6

26.9

742

4856

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

26.9

3507

29907

WX144

NOMESCO Finland

Subconjunctival anesthesy

2.7

26.5

139

507

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

26.4

317

1643

H65.2

ICD-10 Finland

Chronic serous otitis media

4.0

26.4

183

G04BD08

ATC

solifenacin; oral

1.7

26.3

553

3385

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

1.7

26.3

512

3071

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

26.2

947

6563

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

26.1

811

5448

R60.0

ICD-10 Finland

Localized oedema

1.5

26.0

1001

7026

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.6

26.0

665

4275

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

25.9

668

4300

H61.8

ICD-10 Finland

Other specified disorders of external ear

3.9

25.8

199

WX320

NOMESCO Finland

Spinalanesthesy

1.4

25.8

1636

12544

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

25.7

785

5251

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

25.5

1682

12976

B01AB05

ATC

enoxaparin; parenteral

1.3

25.4

2139

17117

A03

ICPC

Fever

1.6

25.4

663

4281

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

25.4

547

3370

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

4.6

25.4

130

DC1AD

NOMESCO Finland

Temporalbone CT

6.2

25.2

N06AX11

ATC

mirtazapine; oral

1.3

25.1

2046

16289

R06.5

ICD-10 Finland

Mouth breathing

1.8

25.1

360

1977

SPAT1058

SPAT

PEF monitoring instruction

1.7

25.1

466

2761

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

2.1

24.9

247

1196

R35

ICD-10 Finland

Polyuria

1.7

24.8

505

3066

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

24.6

991

7012

WZC30

NOMESCO Finland

Teaching

1.5

24.4

944

6625

H66.9

ICD-10 Finland

Otitis media, unspecified

2.3

24.3

184

799

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

8.0

24.3

D19

ICPC

Teeth/gum symptom/complaint

1.4

24.3

1218

8967

R52.9

ICD-10 Finland

Pain, unspecified

1.6

24.2

583

3691

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

24.1

744

4986

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

23.9

630

4074

F29

ICPC

Eye symptom/complaint other

1.6

23.8

551

3455

K86

ICPC

Hypertension uncomplicated

1.4

23.8

1020

7298

N01

ICPC

Headache

1.7

23.7

407

2358

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

23.7

1511

11573

C10AA07

ATC

rosuvastatin; oral

1.3

23.6

1832

14459

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.5

23.5

680

4491

TQW40, ,

SPAT

1.7

23.5

503

3094

WX002

NOMESCO Finland

Sedation and analgesia

1.4

23.5

1301

9739

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

23.4

2331

19046

G04CB02

ATC

dutasteride; oral

1.6

23.4

632

4111

SCA02

NOMESCO Finland

Preventive oral health care

1.7

23.3

425

2503

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

23.0

1394

10581

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

23.0

1350

10195

EBA00

NOMESCO Finland

Extraction of tooth

1.3

22.9

1792

14143

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

22.8

1124

8244

K85

ICPC

Elevated blood pressure

1.4

22.7

1255

9381

H71

ICD-10 Finland

Cholesteatoma of middle ear

4.0

22.7

159

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

22.7

827

5732

U01

ICPC

Dysuria/painful urination

1.7

22.4

477

2930

C01DA14

ATC

isosorbide mononitrate; oral

1.3

22.4

1790

14169

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

22.3

883

6221

S04

ICPC

Lump/swelling localized

1.6

22.2

573

3687

SPAT1252

SPAT

Overall medication plan or its review

1.6

22.2

575

3704

M48.0

ICD-10 Finland

Spinal stenosis

1.4

22.2

975

7004

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

22.1

1045

7602

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

22.1

829

5778

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

22.1

2256

18466

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

22.0

1037

7542

R04.0

ICD-10 Finland

Epistaxis

1.6

21.9

619

4066

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

21.7

1088

7998

H03

ICPC

Tinnitus, ringing/buzzing ear

2.9

21.6

104

363

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

21.6

1249

9402

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

21.5

656

4382

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

21.4

911

6500

M02AA07

ATC

piroxicam; topical

1.3

21.4

2426

20111

R55

ICD-10 Finland

Syncope and collapse

1.4

21.3

939

6742

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

21.3

645

4299

D11

ICPC

Diarrhoea

1.6

21.2

533

3406

R07

ICPC

Sneezing/nasal congestion

2.1

21.2

211

1024

WX290

NOMESCO Finland

Other blockage of nerve

1.3

21.2

1619

12713

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

21.1

1277

9676

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

21.0

361

2091

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.6

21.0

467

2898

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

21.0

1175

8793

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

20.9

507

3213

-30

ICPC

Medical examin/health eval complete

2.2

20.9

178

813

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

20.9

1096

8113

DFE00

NOMESCO Finland

Insertion of cochlear implant

+∞

20.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

20.7

2613

21927

C09AA05

ATC

ramipril; oral

1.3

20.7

2096

17104

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.6

20.6

478

2998

WX720

NOMESCO Finland

Own respiration

1.9

20.6

254

1330

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

20.3

1679

13323

B01AC04

ATC

clopidogrel; oral

1.3

20.3

1426

11052

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

20.3

194

928

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

20.2

1050

7754

S06.0

ICD-10 Finland

Concussion

1.5

20.2

664

4501

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

20.2

1951

15805

C03CA01

ATC

furosemide; systemic

1.3

20.1

3311

28657

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

20.1

294

1626

N03AX16

ATC

[U] pregabalin

1.3

20.0

1342

10324

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

20.0

1050

7769

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

20.0

1730

13808

A01

ICPC

Pain general/multiple sites

1.5

20.0

663

4505

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

19.9

448

2788

38699, ,

ICD-8 Finland

4.6

19.9

102

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

19.8

1124

8420

ZXA05

NOMESCO Finland

Left side

1.3

19.8

1785

14320

S02.51

ICD-10 Finland

Fracture of tooth, open

1.7

19.8

400

2422

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.8

19.8

332

1911

R5110, ,

SPAT

1.5

19.6

671

4589

SPAT1359

SPAT

Use of symptom diary

2.2

19.6

159

713

H60

ICD-10 Finland

Otitis externa

2.1

19.4

188

904

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

19.4

1143

8617

H02.3

ICD-10 Finland

Blepharochalasis

1.6

19.3

420

2592

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

19.3

433

2693

XF600, ,

SPAT

1.9

19.2

255

1368

F03

ICPC

Eye discharge

1.8

19.2

309

1758

R31

ICD-10 Finland

Unspecified haematuria

1.4

19.0

834

5976

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

19.0

1131

8533

R13

ICD-10 Finland

Dysphagia

1.6

19.0

456

2882

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

19.0

475

3032

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

19.0

2582

21799

L05

ICPC

Flank/axilla symptom/complaint

1.7

18.9

369

2214

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

18.9

840

6035

ZXA00

NOMESCO Finland

Right side

1.3

18.8

1888

15348

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

18.8

654

4486

L90

ICPC

Osteoarthrosis of knee

1.6

18.7

455

2886

SPAT1351

SPAT

Extensive ear examination

4.2

18.6

116

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.3

18.6

142

621

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

18.6

820

5884

-1, ,

ICPC

1.9

18.5

224

1165

RK530, ,

NOMESCO Finland

99.1

18.5

SCA03

NOMESCO Finland

Preventive oral health care, extensive

2.0

18.3

189

931

T16

ICD-10 Finland

Foreign body in ear

3.9

18.1

136

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

18.0

1065

8023

P01AB01

ATC

metronidazole; oral, rectal

1.3

18.0

2011

16554

S22

ICPC

Nail symptom/complaint

1.6

18.0

402

2498

R15

ICD-10 Finland

Faecal incontinence

1.9

17.9

216

1123

Z00.8

ICD-10 Finland

Other general examinations

1.6

17.8

433

2747

N02AX02

ATC

tramadol; systemic, rectal

1.3

17.7

2701

23054

U07

ICPC

Urine symptom/complaint other

1.5

17.7

572

3864

DFF16

NOMESCO Finland

Speech-in-noise audiometry

+∞

17.6

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

17.6

1087

8243

J01FA09

ATC

clarithromycin; systemic

1.3

17.5

1377

10819

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

2.4

17.4

114

466

M01AC06

ATC

meloxicam; systemic, rectal

1.3

17.4

1964

16175

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

17.4

1105

8416

A10BK01

ATC

dapagliflozin; oral

1.6

17.3

455

2938

D07AC13

ATC

mometasone; topical

1.3

17.3

1559

12474

C09CA06

ATC

candesartan; oral

1.3

17.2

1343

10533

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.4

17.2

827

6020

KED22

NOMESCO Finland

Transurethral resection of prostate

1.5

17.2

522

3480

L14

ICPC

Leg/thigh symptom/complaint

1.5

17.2

522

3481

XQ848

NOMESCO Finland

Dermatological photography

2.0

17.1

197

1009

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.6

16.9

439

2826

S02

ICPC

Pruritus

1.9

16.9

210

1103

AXX01, ,

SPAT

1.7

16.8

319

1901

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

16.8

1262

9844

OAB44, ,

SPAT

1.6

16.8

377

2345

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.5

16.7

566

3858

AN1

Coronary angiography

1.4

16.7

968

7262

L86

ICPC

Back syndrome with radiating pain

1.7

16.7

336

2034

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

16.6

425

2726

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

16.6

1481

11821

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

16.6

238

1308

DFX00

NOMESCO Finland

Connecting cochlear implant

+∞

16.6

D33.30

ICD-10 Finland

Acoustic neuroma

+∞

16.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

16.6

980

7375

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

16.6

310

1840

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.9

16.5

193

993

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.7

16.5

338

2054

H66.3

ICD-10 Finland

Other chronic suppurative otitis media

5.6

16.5

R06AE09

ATC

levocetirizine; oral

1.5

16.5

525

3535

S01

ICPC

Pain/tenderness of skin

1.7

16.4

274

1577

D01

ICPC

Abdominal pain/cramps general

1.5

16.4

568

3891

R09

ICPC

Sinus symptom/complaint

1.8

16.4

264

1504

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

16.2

302

1791

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.1

16.2

151

717

D12

ICPC

Constipation

1.7

16.2

289

1695

I49.5

ICD-10 Finland

Sick sinus syndrome

1.6

16.1

401

2559

RK220, ,

NOMESCO Finland

5.3

16.0

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

16.0

611

4262

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

16.0

207

1103

DDA00

NOMESCO Finland

Stapedotomy

6.4

15.9

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

15.9

677

4820

H70.1

ICD-10 Finland

Chronic mastoiditis

7.0

15.8

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

15.6

446

2933

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

15.6

1552

12557

H51

ICPC

Ear, I&d/flush/aspiration

2.5

15.5

394

K05

ICPC

Irregular heartbeat other

1.8

15.5

241

1358

S22.3

ICD-10 Finland

Fracture of rib

1.5

15.5

443

2915

H43

ICPC

Ear, Other diagnostic procedure

6.5

15.5

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

15.3

1178

9208

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

15.3

1383

11046

XKC03

NOMESCO Finland

Water cystometry

1.9

15.3

196

1041

Z75.9

ICD-10 Finland

Unspecified problem related to medical facilities and other health care

4.2

15.1

Z3231

NOMESCO Finland

Registered nurse

1.3

15.1

1787

14750

L60.0

ICD-10 Finland

Ingrowing nail

1.7

15.1

250

1435

A06AC51

ATC

ispaghula, combinations; oral

1.7

15.1

286

1705

AXX01

NOMESCO Finland

Memory assessment

3.0

15.1

225

WVA30, ,

SPAT

1.6

15.1

357

2251

Z51.88

ICD-10 Finland

Other specified medical care

2.0

15.1

154

757

H40.0

ICD-10 Finland

Glaucoma suspect

1.5

15.0

519

3552

M02AA10

ATC

ketoprofen; topical

1.3

14.9

960

7310

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

14.8

899

6787

J05AB01

ATC

aciclovir; systemic

1.3

14.8

1153

9026

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

14.8

571

3993

XX2VW

NOMESCO Finland

Radiologic consultation

4.2

14.7

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

14.7

774

5714

D06

ICPC

Abdominal pain localized other

1.5

14.6

419

2758

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

14.6

1084

8429

N06AX21

ATC

duloxetine; oral

1.5

14.5

520

3584

R03DC03

ATC

montelukast; oral

1.4

14.5

685

4965

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

14.5

391

2541

S01EE01

ATC

latanoprost; ophthalmic

1.4

14.4

576

4052

H91.0

ICD-10 Finland

Ototoxic hearing loss

148.4

14.4

XF404

NOMESCO Finland

Ambulatory ECG

1.4

14.4

591

4181

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

14.4

317

1965

R96

ICPC

Asthma

1.5

14.3

507

3485

R07.0

ICD-10 Finland

Pain in throat

1.7

14.3

235

1346

S06

ICPC

Rash localized

1.6

14.3

338

2130

R83

ICPC

Respiratory infection other

1.4

14.3

663

4791

R1250, ,

SPAT

1.9

14.1

182

969

H01.0

ICD-10 Finland

Blepharitis

1.7

14.0

263

1563

H27

ICPC

Fear of ear disease

3.0

13.8

204

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

13.8

2257

19269

H66

ICD-10 Finland

Suppurative and unspecified otitis media

2.7

13.8

264

R03BA08

ATC

ciclesonide; inhalant

1.6

13.8

362

2337

L02

ICPC

Back symptom/complaint

1.5

13.8

435

2922

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

13.8

1279

10234

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.4

13.8

706

5186

S15

ICPC

Foreign body in skin

1.6

13.7

365

2364

ACC51

NOMESCO Finland

Release of median nerve

1.6

13.7

333

2113

A02BA02

ATC

ranitidine; systemic

1.3

13.7

1367

11042

A08

ICPC

Swelling

1.5

13.6

441

2978

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

13.6

599

4289

F16

ICPC

Eyelid symptom/complaint

1.7

13.5

261

1563

M79.1

ICD-10 Finland

Myalgia

1.4

13.5

619

4460

M01AE02

ATC

naproxen; oral, rectal

1.2

13.5

2771

24188

H95.1

ICD-10 Finland

Other disorders following mastoidectomy

+∞

13.5

XQ855, ,

SPAT

2.5

13.5

319

H05

ICPC

Bleeding ear

3.7

13.5

113

R2130, ,

SPAT

2.5

13.4

331

H81.3

ICD-10 Finland

Other peripheral vertigo

1.9

13.4

164

858

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

13.4

558

3953

XF402

NOMESCO Finland

ECG with work load test

1.4

13.4

684

5019

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.7

13.4

224

1290

SPAT1281

SPAT

Other administrative function

1.5

13.4

437

2955

D01AE16

ATC

amorolfine; topical

1.4

13.4

701

5167

R08

ICPC

Nose symptom/complaint other

1.9

13.4

156

804

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

13.4

994

7722

XQ845

NOMESCO Finland

Dermatoscopy

2.1

13.4

130

628

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

13.3

417

2797

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.8

13.3

207

1168

J02AC01

ATC

fluconazole; systemic

1.2

13.3

1657

13729

RK323, ,

NOMESCO Finland

5.5

13.1

F02

ICPC

Red eye

1.7

13.1

224

1300

N05CF01

ATC

zopiclone; oral

1.2

13.1

2297

19731

D02

ICPC

Abdominal pain epigastric

1.6

13.1

289

1793

RK510, ,

NOMESCO Finland

9.5

13.1

I95.1

ICD-10 Finland

Orthostatic hypotension

1.5

13.0

387

2567

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

13.0

164

868

SPAT1098

SPAT

Exercise ECG

2.0

13.0

133

655

F01

ICPC

Eye pain

2.1

13.0

128

622

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

12.9

1169

9317

H68.1

ICD-10 Finland

Obstruction of Eustachian tube

3.2

12.9

155

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.3

12.9

392

B01AF01

ATC

rivaroxaban; oral

1.3

12.8

867

6642

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

12.8

625

4555

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

12.8

182

1001

M01AX17

ATC

nimesulide; oral

1.3

12.7

1505

12387

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

12.7

861

6600

K78

ICPC

Atrial fibrillation/flutter

1.4

12.7

727

5435

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

1.9

12.7

157

826

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

12.7

235

1394

S97

ICPC

Chronic ulcer skin

1.4

12.6

491

3437

S70.0

ICD-10 Finland

Contusion of hip

1.6

12.6

315

2013

R51

ICD-10 Finland

Headache

1.8

12.5

188

1051

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

12.5

498

3502

SPAT1254

SPAT

Administration of medicine

1.3

12.5

1104

8773

C08CA13

ATC

lercanidipine; oral

1.3

12.5

1052

8309

H03AA01

ATC

levothyroxine sodium; systemic

1.3

12.4

1318

10706

L18

ICPC

Muscle pain

1.7

12.4

217

1266

D17

ICPC

Incontinence of bowel

2.3

12.4

374

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

12.4

533

3800

M19.8

ICD-10 Finland

Other specified arthrosis

1.7

12.4

215

1253

RK111, ,

NOMESCO Finland

128.6

12.4

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

12.3

606

4419

ZXH06, ,

SPAT

1.7

12.3

229

1359

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

12.3

539

3854

N04BC05

ATC

pramipexole; oral

1.4

12.3

484

3397

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

12.3

767

5810

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

12.2

434

2987

C05AA08

ATC

fluocortolone; rectal, topical

1.3

12.2

725

5450

K76

ICPC

Ischaemic heart dis without angina

1.7

12.2

201

1155

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

12.2

697

5210

ZXD20

NOMESCO Finland

Day surgery

1.4

12.2

690

5150

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

12.1

768

5830

H65.4

ICD-10 Finland

Other chronic nonsuppurative otitis media

8.8

12.1

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

12.1

1133

9065

R1250

NOMESCO Finland

Evaluation of functional capability

1.9

12.1

150

791

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

12.0

377

2530

R07.3

ICD-10 Finland

Other chest pain

1.4

12.0

589

4295

U71

ICPC

Cystitis/urinary infection other

1.5

11.9

398

2705

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.4

11.9

676

5044

H80

ICD-10 Finland

Otosclerosis

21.0

11.9

J01EA01

ATC

trimethoprim; systemic

1.2

11.9

1775

14966

S01BC05

ATC

ketorolac; ophthalmic

1.5

11.9

342

2255

XX2RW, ,

NOMESCO Finland

2.5

11.9

303

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

11.9

1190

9598

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

11.9

390

2643

RK322, ,

NOMESCO Finland

9.9

11.9

R00.2

ICD-10 Finland

Palpitations

1.5

11.8

321

2089

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

11.8

383

2588

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

11.8

375

2524

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.5

11.8

380

2565

A23

ICPC

Risk factor NOS

1.5

11.8

391

2655

R81

ICPC

Pneumonia

1.7

11.8

218

1294

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

11.7

528

3793

W19

ICD-10 Finland

Unspecified fall

1.4

11.7

659

4909

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.9

11.7

147

777

J45

ICD-10 Finland

Asthma

1.4

11.7

464

3259

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

11.7

259

1608

WX723, ,

SPAT

3.5

11.7

110

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

11.7

166

913

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

1.6

11.7

250

1540

ZXH09

NOMESCO Finland

Procedure performed in other unit outside usual setting for the procedure

4.4

11.7

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

11.7

546

3950

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.0

11.6

160

WVA20, ,

SPAT

1.8

11.6

181

1023

VALMI, ,

NOMESCO Finland

1.3

11.6

913

7140

H70

ICPC

Otitis externa

2.3

11.5

368

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

11.5

618

4570

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

11.5

366

2463

G04BD09

ATC

trospium; oral

1.7

11.5

186

1063

SPAT1059

SPAT

Spirometry at the office

1.6

11.5

268

1685

YHMAS, ,

NOMESCO Finland

3.6

11.5

102

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

11.5

988

7816

K22

ICPC

Risk factor cardiovascular disease

1.5

11.5

399

2734

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.4

11.5

544

3943

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.5

11.5

383

2604

K07

ICPC

Swollen ankles/oedema

1.5

11.5

405

2785

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

11.4

588

4320

R01AD11

ATC

triamcinolone; nasal

1.5

11.4

356

2387

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

11.4

755

5764

H60.1

ICD-10 Finland

Cellulitis of external ear

3.0

11.4

162

3891A

ICD-9 Finland

Deafness, Sensorineural deafness

+∞

11.4

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

+∞

11.4

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.3

11.4

848

6581

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.5

11.4

391

2673

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.5

11.3

1861

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

11.3

581

4269

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.4

11.3

601

4442

SPAT1044

SPAT

Tympanometry

2.4

11.3

323

A10BB01

ATC

glibenclamide; oral

0.6

11.2

235

3639

SGA01

NOMESCO Finland

Emergency treatment

1.4

11.2

418

2902

R12

ICD-10 Finland

Heartburn

1.5

11.2

363

2452

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

11.2

481

3427

L04

ICPC

Chest symptom/complaint

1.5

11.2

320

2107

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

11.2

255

1595

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

11.2

380

2594

H82

ICPC

Vertiginous syndrome

2.0

11.1

120

603

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

11.1

213

1275

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

11.1

276

1761

R03AK08

ATC

formoterol and beclometasone; inhalant

1.7

11.1

190

1103

A02BC04

ATC

rabeprazole; oral

1.5

11.1

357

2408

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

11.1

2119

18285

S09

ICPC

Infected finger/toe

1.8

11.0

168

944

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.7

11.0

183

1054

N06AX26

ATC

vortioxetine; oral

1.6

11.0

254

1593

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

11.0

186

1077

SPAT1229

SPAT

Assessment of need for aid

1.4

11.0

591

4374

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.3

11.0

333

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

10.9

348

2345

M10

ICD-10 Finland

Gout

1.5

10.9

286

1850

R06AX13

ATC

loratadine; oral

1.4

10.8

521

3786

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

1.6

10.8

241

1500

EB1VA, ,

NOMESCO Finland

1.4

10.8

594

4410

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

10.8

375

2571

T90

ICPC

Diabetes non-insulin dependent

1.2

10.8

1556

13055

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

10.8

1471

12270

R50.9

ICD-10 Finland

Fever, unspecified

1.3

10.8

848

6629

K08.80

ICD-10 Finland

Toothache NOS

1.6

10.7

252

1588

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

4.4

10.7

K59.1

ICD-10 Finland

Functional diarrhoea

1.5

10.6

321

2139

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.3

10.6

716

5479

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

10.6

392

2718

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.5

10.6

305

2011

SPAT1291

SPAT

Other function in accordance with NCSP classification

2.1

10.6

433

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.2

10.6

363

AN2

Balloon angioplasty, including several vessels

1.6

10.6

214

1300

D21

ICPC

Swallowing problem

2.0

10.6

111

553

114

Kela drug reimbursment

Glaucoma

1.3

10.6

801

6230

-54

ICPC

Repair/fix-suture/cast/prosth device

1.8

10.5

141

762

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

10.5

869

6838

K59.0

ICD-10 Finland

Constipation

1.4

10.5

408

2858

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

1.8

10.5

140

757

SPAT1016

SPAT

Examination of vision

1.6

10.5

244

1536

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

10.4

969

7735

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.7

10.4

177

1027

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

10.4

189

1117

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

10.4

484

3498

L92

ICPC

Shoulder syndrome

1.9

10.3

125

654

S16

ICPC

Bruise/contusion

1.6

10.3

213

1301

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

10.3

522

3825

J05AB11

ATC

valaciclovir; oral

1.3

10.3

698

5347

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.3

293

1930

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.6

10.2

241

1520

NG1DA

NOMESCO Finland

X-ray of knees

2.1

10.2

466

L72.1

ICD-10 Finland

Trichilemmal cyst

1.5

10.2

316

2118

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

10.2

156

879

WPA44

NOMESCO Finland

Nursing home for palliative care

3.6

10.2

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.6

10.1

246

1564

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.6

10.1

211

1294

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

1.7

10.1

175

1022

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.4

10.1

278

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

10.0

346

2369

R75

ICPC

Sinusitis acute/chronic

1.8

10.0

147

818

H72.9

ICD-10 Finland

Perforation of tympanic membrane, unspecified

3.1

10.0

127

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

10.0

354

2436

J01DA01

ATC

[U] cefalexin

1.2

10.0

3610

32820

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

10.0

358

2471

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

9.9

322

2179

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

9.9

633

4808

F06.7

ICD-10 Finland

Mild cognitive disorder

1.5

9.9

263

1707

L11

ICPC

Wrist symptom/complaint

1.4

9.9

378

2640

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

9.9

269

1755

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

9.8

131

709

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.5

9.8

299

2000

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

9.7

293

1952

WNF00

NOMESCO Finland

Infection source and contact determination

3.2

9.7

119

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

9.7

304

2041

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

9.7

657

5029

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

9.7

450

3250

J20

ICD-10 Finland

Acute bronchitis

1.4

9.7

466

3386

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

9.7

296

1978

X58

ICD-10 Finland

Exposure to other specified factors

1.3

9.7

589

4441

S01.0

ICD-10 Finland

Open wound of scalp

1.3

9.6

548

4091

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

9.6

500

3680

QXB99, ,

SPAT

1.8

9.6

141

785

K02

ICPC

Pressure/tightness of heart

1.8

9.6

148

836

J32.4

ICD-10 Finland

Chronic pansinusitis

2.6

9.6

207

G04BD07

ATC

tolterodine; oral

1.4

9.6

396

2806

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.4

9.5

433

3117

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

9.5

249

1611

R33

ICD-10 Finland

Retention of urine

1.3

9.5

670

5159

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

9.4

2204

19300

M54.2

ICD-10 Finland

Cervicalgia

1.5

9.4

305

2062

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

9.4

932

7491

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.0

9.4

481

Z01.7

ICD-10 Finland

Laboratory examination

1.3

9.4

824

6526

L95

ICPC

Osteoporosis

1.5

9.4

287

1919

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

9.4

1345

11259

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

9.3

208

1296

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

1.6

9.3

237

1523

H60.5

ICD-10 Finland

Acute otitis externa, noninfective

2.8

9.3

154

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.2

9.3

1091

8941

EMAK, ,

NOMESCO Finland

1.7

9.3

147

837

J01FA06

ATC

roxithromycin; oral

1.2

9.3

2185

19142

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

9.3

640

4913

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.4

9.3

398

2838

XKX00

NOMESCO Finland

Pelvic floor electromyography

4.1

9.2

M15

ICD-10 Finland

Polyarthrosis

1.5

9.2

329

2268

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

9.2

831

6607

M01AH02

ATC

rofecoxib; oral

1.3

9.2

834

6634

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

9.2

573

4336

R23

ICPC

Voice symptom/complaint

2.1

9.2

419

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

3.0

9.1

129

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

2.6

9.1

195

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.4

9.1

358

2512

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

9.1

527

3943

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.5

9.1

282

1891

R06

ICPC

Nose bleed/epistaxis

1.7

9.1

172

1029

130

Kela drug reimbursment

Malignant tumour

0.7

9.1

368

5004

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

9.1

206

1290

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.5

9.1

235

1517

R49.09

ICD-10 Finland

Unspecified dysphonia

2.4

9.1

231

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

2.6

9.0

185

S70

ICPC

Herpes zoster

1.7

9.0

172

1032

H25.8

ICD-10 Finland

Other senile cataract

1.2

9.0

973

7902

R44

ICPC

Respiratory, Preventive immunization/medic

1.9

9.0

106

552

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

8.9

171

1026

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

8.9

402

2890

M54

ICD-10 Finland

Dorsalgia

1.4

8.9

484

3586

R11

ICD-10 Finland

Nausea and vomiting

1.3

8.9

526

3947

G04BD11

ATC

fesoterodine; oral

1.6

8.9

203

1272

SPAT1039

SPAT

Otomicroscopy

2.3

8.9

294

K01

ICPC

Heart pain

1.9

8.9

100

512

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.8

8.9

138

783

N48.4

ICD-10 Finland

Impotence of organic origin

1.9

8.8

101

520

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.7

8.8

148

858

J01CA08

ATC

pivmecillinam; oral

1.2

8.8

2304

20347

L29

ICPC

Musculoskeletal sympt/complt other

1.4

8.8

486

3615

K03.66

ICD-10 Finland

Tooth plaque

1.4

8.7

342

2400

H40.11

ICD-10 Finland

Low pressure glaucoma

1.7

8.7

166

995

N05CF02

ATC

zolpidem; oral

1.3

8.7

753

5952

ECB00

NOMESCO Finland

Suture of gingiva

1.6

8.7

179

1094

A29

ICPC

General symptom/complaint other

1.3

8.7

884

7124

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

3.4

8.7

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

1.5

8.7

268

1796

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

8.7

451

3319

D06BB10

ATC

imiquimod; topical

1.5

8.7

298

2040

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

8.7

278

1878

SPF02

NOMESCO Finland

Impression for dental prosthesis repair, restricted

2.0

8.7

469

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.2

8.6

387

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

1.6

8.6

210

1337

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

1.9

8.6

497

H71

ICPC

Acute otitis media/myringitis

3.0

8.6

123

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

2.1

8.6

376

F92

ICPC

Cataract

2.4

8.6

249

L89

ICPC

Osteoarthrosis of hip

1.5

8.6

235

1536

F70

ICPC

Conjunctivitis infectious

2.0

8.6

443

SPAT1118

SPAT

Haemorrhoid procedure

3.0

8.6

118

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

8.6

210

1339

ZYC01, ,

SPAT

1.4

8.6

394

2843

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

8.6

276

1866

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

8.6

561

4275

S00.0

ICD-10 Finland

Superficial injury of scalp

1.7

8.5

161

963

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

8.5

557

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.3

8.5

608

4688

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

8.5

220

1420

M75

ICD-10 Finland

Shoulder lesions

1.6

8.5

179

1101

N02BF02

ATC

pregabalin; oral

1.5

8.5

286

1951

M02AA15

ATC

diclofenac; topical

1.4

8.5

397

2873

S03

ICPC

Warts

2.0

8.5

418

K08.3

ICD-10 Finland

Retained dental root

1.4

8.5

424

3102

XQ858, ,

SPAT

2.7

8.5

168

RK321, ,

NOMESCO Finland

8.1

8.5

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

8.5

359

S10

ICPC

Boil/carbuncle

1.5

8.4

266

1791

H65.0

ICD-10 Finland

Acute serous otitis media

2.5

8.4

203

S02.5

ICD-10 Finland

Fracture of tooth

1.9

8.4

480

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

1.7

8.4

142

824

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

9.9

8.4

U05

ICPC

Urination problems other

1.4

8.4

371

2658

E03

ICD-10 Finland

Other hypothyroidism

1.5

8.4

283

1930

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.5

8.4

232

1519

WPA11

NOMESCO Finland

Developing a plan for palliative care

3.1

8.4

104

A03FA02

ATC

cisapride; oral, rectal

1.3

8.4

518

3916

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.8

8.3

112

609

N39.3

ICD-10 Finland

Stress incontinence

1.4

8.3

363

2598

38990

ICD-8 Finland

Other deafness, Partialis uni-sive bilateralis

+∞

8.3

WZB00, ,

SPAT

1.5

8.3

292

2011

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.6

8.2

199

1266

R41.0

ICD-10 Finland

Disorientation, unspecified

1.5

8.2

282

1931

R03BA01

ATC

beclometasone; inhalant

1.3

8.2

770

6146

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.0

8.2

410

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.2

8.2

1750

15178

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.5

8.2

272

1853

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

8.1

615

4779

D01AE15

ATC

terbinafine; topical

1.4

8.1

397

2894

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

1.4

8.1

386

2801

P03

ICPC

Feeling depressed

1.5

8.1

232

1531

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

8.1

333

2357

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.4

8.1

989

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.4

8.1

425

3134

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.3

8.1

681

5365

R06AX22

ATC

ebastine; oral

1.3

8.1

607

4712

R04

ICPC

Breathing problem other

1.6

8.1

178

1108

CBB30

NOMESCO Finland

Excision of lesion of eyelid

1.6

8.1

180

1124

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

8.1

458

3419

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.8

8.1

121

680

Y85

ICPC

Benign prostatic hypertrophy

1.8

8.1

120

673

-45

ICPC

Observ/health educat/advice/diet

1.7

8.0

156

941

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.5

8.0

253

1705

F05

ICPC

Visual disturbance other

1.6

8.0

173

1072

C10AX09

ATC

ezetimibe; oral

1.2

8.0

852

6902

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.0

2313

20552

H92.2

ICD-10 Finland

Otorrhagia

6.7

8.0

D07AD01

ATC

clobetasol; topical

1.3

8.0

774

6206

R04.2

ICD-10 Finland

Haemoptysis

1.5

7.9

229

1515

M01AC01

ATC

piroxicam; systemic, rectal

1.3

7.9

771

6182

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

3.0

7.9

108

OAB48

NOMESCO Finland

Lifestyle advice and guidance

3.0

7.9

108

WZC30, ,

SPAT

1.4

7.9

381

2772

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.5

7.9

201

1294

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.4

7.9

379

2756

SPAT1216

SPAT

Assessment of functional ability

1.2

7.9

1196

10055

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.5

7.8

206

1336

SPA02

NOMESCO Finland

Preparation for dental prosthetics

1.7

7.8

146

872

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.7

7.8

138

812

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

7.8

383

2794

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.8

207

1345

T92

ICPC

Gout

1.7

7.8

135

790

U13

ICPC

Bladder symptom/complaint other

1.6

7.8

194

1243

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.3

7.8

515

3930

L19

ICPC

Muscle symptom/complaint NOS

1.7

7.8

136

798

-40

ICPC

Diagnostic endoscopy

3.8

7.8

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.0

7.8

391

K05.30

ICD-10 Finland

Periodontitis complex

1.3

7.8

674

5331

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

7.7

271

1864

M65.3

ICD-10 Finland

Trigger finger

1.6

7.7

184

1167

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.6

7.7

191

1222

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.5

7.7

199

1286

R07.2

ICD-10 Finland

Precordial pain

1.8

7.7

119

675

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

1.4

7.7

363

2633

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.0

7.7

427

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

7.7

213

1398

M10.9

ICD-10 Finland

Gout, unspecified

1.3

7.7

488

3704

R03BA05

ATC

fluticasone; inhalant

1.2

7.7

862

7025

H86

ICPC

Deafness

44.5

7.7

SPAT1054

SPAT

Examination of peripheral nervous system

1.9

7.7

469

H73.1

ICD-10 Finland

Chronic myringitis

14.8

7.6

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

7.6

707

5635

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

2.7

7.6

143

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.5

7.6

212

1392

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.8

7.6

132

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

7.6

112

626

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

7.6

330

2359

R5140, ,

SPAT

2.0

7.6

401

ZXD05

NOMESCO Finland

Urgent procedure

1.2

7.6

1785

15584

F21, ,

ICPC

1.9

7.6

463

A51

ICPC

General and Unspecified, I&d/flush/aspiration

6.3

7.6

L76

ICPC

Fracture: other

1.5

7.6

208

1362

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

7.6

237

1595

H31

ICPC

Ear, Medical examin/health eval partial

5.8

7.6

H90

ICD-10 Finland

Conductive and sensorineural hearing loss

5.8

7.6

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.4

7.6

340

2446

H65.9

ICD-10 Finland

Nonsuppurative otitis media, unspecified

4.1

7.6

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

1.6

7.6

154

941

Z04

ICD-10 Finland

Examination and observation for other reasons

1.9

7.6

464

S01ED51

ATC

timolol, combinations; ophthalmic

1.3

7.5

624

4907

F13

ICPC

Eye sensation abnormal

1.7

7.5

120

687

R1430, ,

SPAT

2.1

7.5

316

H72.8

ICD-10 Finland

Other perforations of tympanic membrane

4.3

7.5

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

1.8

7.5

112

629

B02.9

ICD-10 Finland

Zoster without complication

1.3

7.5

413

3069

R25.2

ICD-10 Finland

Cramp and spasm

1.7

7.5

117

666

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

7.5

194

1255

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

7.5

144

868

I49.1

ICD-10 Finland

Atrial premature depolarization

1.5

7.5

191

1232

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

1.4

7.5

285

1993

K02

ICD-10 Finland

Dental caries

1.5

7.5

252

1722

H83.9

ICD-10 Finland

Disease of inner ear, unspecified

6.1

7.4

N06DX01

ATC

memantine; oral

1.2

7.4

867

7093

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.5

7.4

1533

R1100, ,

SPAT

2.0

7.4

351

R01AD59

ATC

mometasone, combinations; nasal

1.7

7.4

120

691

-60

ICPC

Result test/procedure

1.4

7.4

350

2542

SPAT1236

SPAT

Informing family of child’s disability

1.7

7.4

121

699

SAA04

NOMESCO Finland

Special examination of mouth

1.5

7.4

195

1268

KDV10

NOMESCO Finland

Internal urethrotomy

1.9

7.3

441

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

7.3

357

2603

J01

ICD-10 Finland

Acute sinusitis

1.6

7.3

145

880

M05BX04

ATC

denosumab; parenteral

1.3

7.3

452

3417

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

2.6

7.3

152

SBB10

NOMESCO Finland

Dental impressions

1.6

7.3

181

1159

ZY010

NOMESCO Finland

Hospital outpatient

1.6

7.3

147

896

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

7.3

157

973

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

7.3

532

R61

ICD-10 Finland

Hyperhidrosis

2.5

7.3

170

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.6

7.3

146

890

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.6

7.2

174

1107

AN4

Balloon angioplasty and drug eluding stent

1.5

7.2

219

1465

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.7

7.2

124

725

H10

ICD-10 Finland

Conjunctivitis

1.5

7.2

210

1394

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.6

7.2

143

870

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

7.2

470

3584

R4180

NOMESCO Finland

Podiatric therapy

2.1

7.2

283

SPAT1202

SPAT

Intra-articular injection

1.5

7.2

191

1244

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

2.6

7.1

154

M54.3

ICD-10 Finland

Sciatica

1.4

7.1

268

1869

R30.0

ICD-10 Finland

Dysuria

1.5

7.1

190

1237

S80.0

ICD-10 Finland

Contusion of knee

1.4

7.1

295

2094

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

7.1

248

1706

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

7.1

332

2405

D06BX01

ATC

metronidazole; topical

1.3

7.1

441

3337

XJH10

NOMESCO Finland

Anorectal manometry

3.4

7.1

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.6

7.1

164

1035

OAB76

NOMESCO Finland

General guidance on nutrition and food

2.9

7.1

110

K35.9

ICD-10 Finland

Acute appendicitis, unspecified

1.5

7.1

196

1288

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.2

7.1

738

5966

N80

ICPC

Head injury other

1.7

7.1

111

634

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

7.0

572

4487

NB1AA, ,

SPAT

1.8

7.0

107

605

S01.3

ICD-10 Finland

Open wound of ear

2.1

7.0

318

-35

ICPC

Urine test

2.1

7.0

318

M77.4

ICD-10 Finland

Metatarsalgia

1.5

7.0

205

1361

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.0

7.0

325

DFF59

NOMESCO Finland

Other assessment of balance

2.8

7.0

116

L84

ICD-10 Finland

Corns and callosities

1.5

7.0

193

1267

H81.2

ICD-10 Finland

Vestibular neuronitis

1.8

7.0

484

S01AD03

ATC

aciclovir; ophthalmic

1.5

7.0

181

1172

S26

ICPC

Fear of cancer of skin

1.9

7.0

435

I50

ICD-10 Finland

Heart failure

1.4

7.0

316

2278

J45.1

ICD-10 Finland

Nonallergic asthma

1.4

7.0

370

2736

WX140

NOMESCO Finland

Parabulbar anesthesy

1.4

7.0

319

2304

A06AD11

ATC

lactulose; oral

1.2

7.0

1317

11284

S08

ICPC

Skin colour change

1.4

7.0

306

2195

M05BA04

ATC

alendronic acid; oral

1.2

7.0

732

5921

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.5

7.0

175

1126

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.6

7.0

136

824

K25

ICPC

Fear of hypertension

1.5

6.9

238

1633

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

6.9

221

1495

R29

ICPC

Respiratory symptom/complaint other

1.4

6.9

283

2005

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.5

6.9

197

1302

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

6.9

305

2189

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

6.9

305

2189

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

6.9

339

2476

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.2

6.9

236

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

1.9

6.9

458

G45.4

ICD-10 Finland

Transient global amnesia

1.6

6.9

134

811

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.3

6.9

199

L29.9

ICD-10 Finland

Pruritus, unspecified

1.6

6.9

140

857

D40

ICPC

Digestive, Diagnostic endoscopy

2.7

6.9

123

D93

ICPC

Irritable bowel syndrome

2.4

6.9

175

D16

ICPC

Rectal bleeding

1.7

6.8

126

752

N29

ICPC

Neurological sympt/complt other

1.7

6.8

107

611

M01AH01

ATC

celecoxib; oral

1.2

6.8

990

8280

UDM02

NOMESCO Finland

Sinoscopy

1.9

6.8

397

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

6.8

250

1738

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.4

6.8

249

1730

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.4

6.8

283

2012

ICB01, ,

SPAT

2.6

6.8

141

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.0

6.8

330

S12

ICPC

Insect bite/sting

1.3

6.8

458

3510

TQW99

NOMESCO Finland

Other minor procedure on skin

1.4

6.7

341

2503

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.3

6.7

427

3242

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.4

6.7

263

1849

S01EE05

ATC

tafluprost; ophthalmic

1.4

6.7

242

1677

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.4

6.7

341

2507

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.4

6.7

296

2127

F05.9

ICD-10 Finland

Delirium, unspecified

1.5

6.7

187

1233

AA3AD

NOMESCO Finland

CT of face

2.2

6.6

221

A10BK03

ATC

empagliflozin; oral

1.3

6.6

539

4230

H40.9

ICD-10 Finland

Glaucoma, unspecified

1.6

6.6

150

943

Y06

ICPC

Prostate symptom/complaint

1.5

6.6

188

1243

R30.1

ICD-10 Finland

Vesical tenesmus

1.7

6.6

112

654

C10AA03

ATC

pravastatin; oral

1.3

6.6

515

4021

A10AA02, ,

ATC

0.6

6.6

1491

S01EC04

ATC

brinzolamide; ophthalmic

1.4

6.6

310

2250

R99

ICPC

Respiratory disease other

1.9

6.6

444

SPAT1360

SPAT

Extensive global examination

1.3

6.6

426

3245

QDB10, ,

SPAT

1.6

6.6

141

875

W17

ICD-10 Finland

Other fall from one level to another

1.5

6.5

182

1198

EB4VA, ,

NOMESCO Finland

1.3

6.5

362

2696

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.5

6.5

171

1112

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.0

6.5

335

M54.1

ICD-10 Finland

Radiculopathy

1.6

6.5

159

1018

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

2.4

6.5

180

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

1.6

6.5

146

917

-, ,

ICD-10 Finland

0.4

6.5

816

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.3

6.5

528

4146

SFA00

NOMESCO Finland

Small restoration

1.3

6.4

517

4051

WX704

NOMESCO Finland

Intubation

1.4

6.4

342

2531

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.3

6.4

520

4079

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

2.1

6.4

263

M79.7

ICD-10 Finland

Fibromyalgia

1.8

6.4

556

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.7

6.4

101

578

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

6.4

362

2704

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

3.1

6.4

M01AH03

ATC

valdecoxib; oral

1.4

6.4

269

1918

H93.8

ICD-10 Finland

Other specified disorders of ear

7.3

6.3

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

1.6

6.3

139

868

R2110

NOMESCO Finland

Giving the first information

1.4

6.3

266

1896

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.3

6.3

431

3307

H76

ICPC

Foreign body in ear

2.4

6.3

158

4289X

ICD-9 Finland

Heart failure, unspecified

0.2

6.3

337

ZX114, ,

SPAT

2.0

6.3

325

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

6.3

376

2831

Y94.0

ICD-10 Finland

Accident at home

1.6

6.3

124

754

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

6.3

399

3031

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.4

6.3

328

2422

A35

ICPC

General and Unspecified, Urine test

2.3

6.3

189

C09CA03

ATC

valsartan; oral

1.3

6.3

573

4562

I21.2

ICD-10 Finland

Acute transmural myocardial infarction of other sites

0.2

6.3

313

QCB10, ,

SPAT

2.0

6.2

333

K29

ICPC

Cardiovascular sympt/complt other

1.4

6.2

298

2170

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.3

6.2

334

2476

AA5PD

NOMESCO Finland

CT examination of brain pefusion

2.0

6.2

293

H91.3

ICD-10 Finland

Deaf mutism, not elsewhere classified

+∞

6.2

NA3AA, ,

SPAT

1.6

6.2

128

787

Z96.2

ICD-10 Finland

Presence of otological and audiological implants

17.8

6.2

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

1.6

6.2

136

849

TKD00

NOMESCO Finland

Dilatation of urethra

2.0

6.2

300

JN4AD

NOMESCO Finland

Body CT examination

1.2

6.2

678

5511

T29

ICPC

Endocr/metab/nutr sympt/compl other

1.7

6.2

563

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

1.7

6.2

563

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.3

6.1

507

3987

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.6

6.1

121

736

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

1.8

6.1

426

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.2

6.1

670

5443

EBB10

NOMESCO Finland

Insertion of dental implant

2.1

6.1

242

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.5

6.1

185

1240

K96

ICPC

Haemorrhoids

1.6

6.1

118

714

R49.08

ICD-10 Finland

Other specified dysphonia

1.8

6.1

477

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

6.1

506

K04.0

ICD-10 Finland

Pulpitis

1.5

6.1

185

1241

C01BC04

ATC

flecainide; systemic

1.5

6.1

195

1322

H74.1

ICD-10 Finland

Adhesive middle ear disease

4.9

6.1

G03CA04

ATC

estriol; systemic, vaginal

1.2

6.1

613

4935

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

6.1

211

1453

R01AD05

ATC

budesonide; nasal

1.4

6.1

295

2155

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

2.2

6.1

211

KED33

NOMESCO Finland

Transurethral incision of prostate

1.8

6.1

500

UJD10, ,

SPAT

1.6

6.0

116

701

R41.3

ICD-10 Finland

Other amnesia

1.4

6.0

239

1686

ZXE20

NOMESCO Finland

More than three and less than five hours

1.2

6.0

802

6648

M01AE03

ATC

ketoprofen; systemic, rectal

1.1

6.0

2173

19524

Z93

ICD-10 Finland

Artificial opening status

3.5

6.0

XA421, ,

SPAT

2.7

6.0

115

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

5253

38478

2.32

208.32

29.1

27.4

14.01

14.13

8.72

5161

37870

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6107

49071

2.60

175.83

23.1

21.8

26.81

29.95

mg/l

11.32

5415

42697

(3031040) Bacteria [#/volume] in Urine by Automated count

5164

38827

2.14

172.40

6.6

5.9

3429.16

2342.86

e6/l

0.52

157

715

(3023103) Potassium [Moles/volume] in Serum or Plasma

6248

51036

2.69

168.45

29.8

27.3

4.02

4.01

mmol/l

0.71

6120

49765

(3019550) Sodium [Moles/volume] in Serum or Plasma

6244

50996

2.69

168.24

29.4

27.1

139.36

139.40

mmol/l

0.56

6126

49804

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6260

51291

2.68

165.61

32.1

29.3

88.62

86.65

umol/l

3.18

6190

50295

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5761

45536

2.30

164.63

7.8

7.5

41.11

40.99

mmol/mol

0.44

4970

41310

(3010813) Leukocytes [#/volume] in Blood

6264

51394

2.68

164.20

35.3

32.4

7.15

7.12

e9/l

0.17

6079

49557

(3035941) MCH [Entitic mass]

6263

51383

2.68

164.18

35.1

32.3

30.44

30.40

1.06

6180

50425

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6263

51386

2.68

164.10

35.7

32.9

38.73

38.70

0.12

6178

50404

(3026361) Erythrocytes [#/volume] in Blood

6263

51386

2.68

164.10

35.2

32.4

4.27

4.28

e12/l

1.32

6077

49546

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6263

51386

2.68

164.10

35.2

32.3

92.19

92.06

1.49

6180

50425

(3000963) Hemoglobin [Mass/volume] in Blood

6263

51392

2.68

163.94

35.6

32.6

128.87

129.02

g/l

0.33

6179

50463

(3007461) Platelets [#/volume] in Blood

6262

51385

2.67

163.81

35.3

32.4

232.05

239.16

e9/l

14.51

6122

49805

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5695

44905

2.25

162.01

6.0

5.5

2.11

2.10

mu/l

0.23

4890

40256

(3041096) Erythrocytes [Presence] in Urine by Automated

2401

14006

2.04

161.38

4.8

4.3

0.06

0.49

estimate

2.21

990

4771

(3037467) Urinalysis macro (dipstick) panel - Urine

5055

38126

2.06

161.15

5.9

5.3

2.61

2.00

0.44

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6137

50010

2.52

160.65

13.9

13.0

22.87

23.61

u/l

1.83

5782

47883

(40761536) Microorganisms panel - Urine sediment

1050

4358

2.62

159.13

5.6

4.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5806

46462

2.26

153.93

6.2

5.8

6.12

6.16

mmol/l

1.59

4672

41084

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5799

46440

2.25

152.52

6.6

6.2

2.33

2.43

mmol/l

14.09

4801

41662

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5654

44911

2.18

150.47

5.6

5.2

4.22

4.33

mmol/l

11.25

4770

40333

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

5023

38274

2.00

148.91

5.0

4.5

15.56

16.49

mm/h

3.07

4420

35001

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5367

42045

2.05

144.56

8.4

8.2

82.77

84.74

u/l

1.20

4944

39489

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5584

44397

2.12

144.25

5.5

5.1

1.43

1.45

mmol/l

2.38

4572

39585

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4888

37088

1.96

144.11

4.6

4.3

15.23

15.26

pmol/l

0.36

4124

32969

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5694

45652

2.15

143.14

25.1

22.5

66.27

68.02

ml/min/173m2

10.14

5396

42932

(3009261) Glucose [Presence] in Urine by Test strip

4078

29265

1.88

141.45

4.8

4.6

0.82

0.39

estimate

0.22

1228

6096

(3018418) pH of Serum or Plasma

3115

20535

1.88

141.20

4.5

4.1

7.40

0.27

2284

14957

(3035350) Ketones [Presence] in Urine by Test strip

4047

29063

1.87

139.05

4.8

4.6

1.01

4.14

estimate

1.56

1290

6505

(3021601) Nitrite [Presence] in Urine by Test strip

3990

28691

1.85

134.72

4.8

4.6

0.00

estimate

1.60

1246

6201

(3021589) Normoblasts [#/volume] in Blood

3421

23463

1.85

134.64

16.2

12.7

0.00

e9/l

0.29

2773

18741

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4420

32853

1.86

133.69

6.8

7.1

1.22

1.21

mmol/l

3.14

3469

28067

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1365

6884

2.18

131.00

4.4

4.1

—

(3032080) INR in Blood by Coagulation assay

4295

31753

1.84

130.85

22.1

21.2

1.38

1.41

inr

2.80

3743

26875

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5366

42611

1.98

130.80

4.5

4.4

1.21

1.24

mmol/l

2.94

4294

37375

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1157

5477

2.30

129.48

4.1

3.9

1.22

1.23

mmol/l

0.47

921

4686

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4032

29425

1.81

126.13

6.0

6.5

1.21

mmol/l

5.38

3597

26923

(1761868) Lipid panel - Serum or Plasma

1994

11724

1.94

124.88

4.3

3.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2686

17422

1.84

123.61

2.1

1.9

1.24

1.26

mmol/l

0.65

1831

14174

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3524

24813

1.80

123.26

2.6

2.4

82.02

80.38

nmol/l

2.66

2929

21564

(3013826) Glucose [Moles/volume] in Serum or Plasma

4580

34967

1.82

120.77

5.0

5.1

6.84

6.94

mmol/l

2.81

4393

33320

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3021

20844

1.75

108.81

5.0

4.9

0.50

0.40

estimate

0.07

1026

5006

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2168

13625

1.82

107.20

2.0

1.8

12517030.05

18165562.94

pmol/l

0.25

1510

10889

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3077

21526

1.72

104.02

2.3

—

(3018095) Leukocytes [#/volume] in Urine

3313

23699

1.71

102.84

4.8

4.5

144.14

145.19

e6/l

0.02

2432

17297

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3315

23847

1.70

99.71

3.5

2068.90

2211.27

ng/l

0.90

2810

21074

(3002582) Erythrocytes [#/volume] in Urine

3104

21974

1.70

98.86

4.0

3.8

182.09

92.48

e6/l

0.83

2371

17026

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3280

23585

1.69

98.36

3.4

3.2

153.64

155.89

ug/l

0.08

2779

21314

(3000850) Epithelial cells [#/volume] in Urine

2337

15452

1.73

94.53

3.2

2.9

5.42

5.34

e6/l

0.11

2098

14018

(3021960) Folate [Moles/volume] in Serum or Plasma

2879

20174

1.69

93.78

1.9

1.8

20.41

19.83

nmol/l

1.10

2264

17072

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3361

24581

1.66

92.44

5.2

4.6

83.88

103.47

ng/l

0.28

2744

20099

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4025

31012

1.65

88.61

5.8

6.2

12.58

12.81

umol/l

0.40

3761

29448

(36304419) Bacteria [Presence] in Urine

2606

18043

1.67

87.10

3.8

3.7

0.86

527.26

estimate

—

129

(3030467) Casts [#/volume] in Urine by Automated count

2723

19133

1.66

85.53

3.9

3.7

0.57

0.55

e6/l

0.13

2034

14432

(3029937) Albumin [Presence] in Urine by Test strip

2414

16508

1.67

83.83

5.1

4.7

0.00

estimate

0.05

1157

5468

(3022096) Basophils/Leukocytes in Blood

3407

25416

1.62

83.45

6.2

6.1

0.62

0.10

3103

23490

(3019069) Monocytes/Leukocytes in Blood

3408

25461

1.62

82.69

6.2

6.1

9.35

9.21

1.77

3103

23504

(3006504) Eosinophils/Leukocytes in Blood

3401

25407

1.62

82.46

6.1

6.0

2.74

2.77

0.27

3096

23468

(3002030) Lymphocytes/Leukocytes in Blood

3420

25713

1.60

79.77

6.1

24.64

24.56

0.15

3153

24038

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2700

19255

1.62

77.89

6.9

6.3

6.38

4.60

ug/l

0.37

2231

16977

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2554

17995

1.63

77.24

2.6

62.69

66.68

u/l

0.36

2270

16554

(3026008) Bacteria identified in Urine by Culture

3112

23150

1.58

73.99

4.1

3.9

—

(40767503) Oxygen content in Capillary blood by calculation

399

1498

2.73

71.89

2.8

2.7

16.25

15.65

3.45

394

1460

(3024561) Albumin [Mass/volume] in Serum or Plasma

3756

29375

1.55

70.20

4.7

4.8

34.17

34.00

g/l

0.98

3360

27101

(3018010) Neutrophils/Leukocytes in Blood

3301

25136

1.55

69.19

5.9

6.0

59.87

59.93

0.10

3103

23707

(40760892) CBC W Ordered Manual Differential panel - Blood

1559

9900

1.71

69.18

5.0

4.7

—

(3025159) Blasts/Leukocytes in Blood

895

4803

1.96

68.96

4.2

4.1

0.47

0.29

0.24

216

1351

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3587

27845

1.55

68.75

3.3

3.2

59.76

58.60

u/l

0.18

3136

25092

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2211

15437

1.60

67.20

5.7

5.1

22.30

22.51

0.25

1126

8567

(3013115) Eosinophils [#/volume] in Blood

3564

27822

1.53

65.18

5.9

0.20

e9/l

0.14

2981

23341

(3001604) Monocytes [#/volume] in Blood

3475

27043

1.52

64.04

5.7

0.66

0.64

e9/l

2.83

2819

22307

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3680

28995

1.52

63.95

2.5

2.4

92.58

92.30

pmol/l

0.13

1813

15240

(3026782) Osmolality of Urine

1982

13619

1.61

63.72

3.2

3.1

506.84

527.19

mosm/kgh2o

5.00

1735

11883

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1695

11240

1.64

62.86

3.9

3.6

0.86

0.89

ug/l

0.28

1148

8349

(3006315) Basophils [#/volume] in Blood

3480

27167

1.52

62.67

5.7

0.04

e9/l

0.21

2816

22460

(3015736) pH of Urine

3069

23365

1.52

62.01

3.8

4.1

6.17

6.33

10.87

1520

12106

(3019198) Lymphocytes [#/volume] in Blood

3519

27611

1.51

61.34

5.8

1.86

1.84

e9/l

0.11

2981

23334

(3021440) Promyelocytes/Leukocytes in Blood

874

4853

1.89

60.29

4.2

3.9

0.10

0.03

212

1472

(3002179) Metamyelocytes/Leukocytes in Blood

859

4750

1.89

60.01

4.0

3.9

0.62

0.66

0.21

226

1555

(3017181) Myelocytes/Leukocytes in Blood

903

5082

1.86

59.69

4.1

3.9

0.87

0.97

0.45

240

1687

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2537

18674

1.53

59.25

2.5

2.78

3.05

mg/l

7.36

2065

15947

(3013650) Neutrophils [#/volume] in Blood by Automated count

3845

30881

1.50

58.81

8.1

8.8

4.51

4.52

e9/l

0.09

3206

26070

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2660

19911

1.51

56.70

2.2

208.67

229.32

u/l

0.79

2454

18648

(3015377) Calcium [Moles/volume] in Serum or Plasma

2912

22267

1.49

55.63

3.2

3.4

2.35

mmol/l

0.75

2568

19788

(3012501) Base excess in Blood by calculation

353

1426

2.52

54.68

3.8

4.5

2.61

2.93

mmol/l

1.12

216

1009

(3013290) Carbon dioxide [Partial pressure] in Blood

353

1428

2.52

54.52

3.8

4.5

4.85

5.04

kpa

4.43

347

1379

(3028271) Lactate [Moles/volume] in Capillary blood

297

1106

2.72

54.24

2.0

1.9

1.64

1.68

mmol/l

0.39

290

1072

(3023368) Bacteria identified in Blood by Culture

2756

20923

1.49

54.11

4.5

—

(3027315) Oxygen [Partial pressure] in Blood

353

1434

2.51

54.03

3.8

4.5

8.41

8.24

kpa

1.19

347

1384

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1845

12923

1.55

52.75

2.0

—

(1616796) Gas panel - Central venous blood

379

1626

2.37

51.45

3.7

3.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1678

11597

1.56

50.58

2.8

2.6

2.24

2.22

g/l

0.67

1471

10577

(3022948) Iron [Moles/volume] in Serum or Plasma

1758

12299

1.55

50.09

2.8

2.7

23.52

11.16

umol/l

0.52

1584

11249

(3019309) Folate [Moles/volume] in Red Blood Cells

1988

14305

1.52

49.63

2.0

1.8

1205.95

1147.09

nmol/l

1.73

1325

10577

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1579

10846

1.56

48.62

2.8

2.7

21.09

20.22

1.85

1408

9950

(3010421) pH of Blood

449

2117

2.17

48.61

3.7

3.9

7.42

7.41

3.30

443

2072

(40768804) Tissue Pathology biopsy report

2658

20416

1.46

47.29

2.5

2.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

393

1797

2.23

45.88

2.6

2.3

127.34

125.10

g/l

1.14

344

1390

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1368

9204

1.58

45.76

1.3

1.2

1.51

1.54

u/ml

0.03

312

2104

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1423

9946

1.52

39.32

1.9

—

(40768797) Stomach Pathology biopsy report

1099

7266

1.58

38.99

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2105

15908

1.44

38.96

3.1

36.52

38.35

u/l

0.35

1910

14794

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1604

11542

1.48

38.30

1.6

1.7

1.48

1.68

mg/l

1.08

1216

9201

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1346

9369

1.52

37.74

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1961

14712

1.44

37.48

3.0

366.13

365.80

umol/l

0.04

1544

12425

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1861

13847

1.44

37.13

4.9

4.5

235.09

466.12

ng/l

2.41

1721

12468

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

331

1562

2.15

35.65

3.1

2.4

1.83

1.88

mg/l

0.41

267

1349

(3007164) IgA [Mass/volume] in Serum or Plasma

1181

8126

1.52

34.65

1.7

1.5

2.61

2.82

g/l

1.83

599

4289

(3022145) Colonoscopy Study observation

852

5513

1.60

32.71

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1082

7412

1.52

32.20

1.3

45.06

44.86

iu/ml

0.01

321

2268

(3014051) Protein [Presence] in Urine by Test strip

1905

14566

1.40

31.63

3.6

0.07

0.05

603

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3109

25726

1.34

31.13

3.0

—

estimate

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1426

10388

1.44

31.02

1.9

30.37

30.08

1.02

1364

10086

(3012516) Albumin [Mass/volume] in Urine

2455

19657

1.36

30.33

3.6

3.4

55.68

53.65

mg/l

0.08

1481

12874

(3048689) Calprotectin [Mass/mass] in Stool

749

4787

1.61

30.15

1.9

164.18

178.14

ug/g

0.43

546

3706

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

719

4557

1.62

29.95

5.5

6.6

24.54

24.89

mmol/l

1.81

713

4508

(3000012) Reticulocyte production index

266

1246

2.15

29.20

2.3

2.1

0.89

0.87

0.21

170

885

(3021901) Oxygen saturation in Capillary blood

329

1684

1.97

28.42

3.0

89.10

88.35

1.11

316

1635

(3035933) Granulocytes/Leukocytes in Blood

233

1050

2.23

28.17

3.4

3.3

56.95

59.80

2.32

233

1050

(3009508) Creatinine [Moles/volume] in Urine

2450

19773

1.34

28.17

3.6

3.4

6.48

6.63

mmol/l

1.07

1785

16223

(3002256) Pathology report gross observation

1075

7572

1.47

27.55

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

997

6946

1.49

26.96

1.3

11.74

17.10

u/ml

1.36

305

2288

(3020682) Albumin/Creatinine [Ratio] in Urine

2491

20280

1.33

26.55

4.5

4.1

9.00

10.21

mg/mmol

0.80

1378

12757

(3028626) Oxygen [Partial pressure] in Capillary blood

354

1914

1.87

25.94

2.9

3.0

7.81

7.69

kpa

0.71

344

1862

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

982

6922

1.46

24.87

3.7

3.2

243.50

291.01

ng/l

3.12

908

6357

(3040151) Glucose [Moles/volume] in Capillary blood

202

917

2.21

24.03

4.0

16.0

7.05

7.51

mmol/l

1.30

167

765

(3027945) Reticulocytes/Erythrocytes in Blood

1285

9579

1.40

23.79

2.5

2.3

1.79

0.08

1077

8353

(3042631) Mycobacterium sp identified in Specimen

206

957

2.16

23.15

3.6

2.6

—

(3023520) Reticulocytes [#/volume] in Blood

1013

7342

1.42

21.89

2.8

2.4

67.25

68.15

e9/l

0.34

704

5294

(3000494) Fungus identified in Specimen by Culture

820

5768

1.46

20.77

1.5

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

139

573

2.42

20.74

1.6

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

414

2508

1.67

20.46

2.9

3.2

24.85

24.94

mmol/l

0.17

403

2458

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

179

829

2.16

20.32

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1833

14763

1.30

19.78

3.1

3.2

2.47

2.48

mmol/l

1.54

1591

12992

(3049717) Cytology report of Urine Cyto stain

476

3022

1.60

19.49

2.7

2.9

—

(3047181) Lactate [Moles/volume] in Blood

325

1905

1.72

18.18

4.7

5.2

1.33

1.38

mmol/l

0.33

268

1690

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1394

10973

1.32

17.47

2.7

2.8

0.81

mmol/l

0.26

1260

10095

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

832

6064

1.40

17.16

2.0

0.19

g/l

0.03

734

5532

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

377

2.59

16.99

4.7

3.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

558

3811

1.48

16.32

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

669

4737

1.44

16.21

2.0

2.2

385.48

398.86

nmol/l

0.83

613

4277

(3037522) Nuclear Ab [Titer] in Serum

786

5728

1.40

16.18

1.3

452.54

487.30

titre

0.28

201

1369

(3005719) IgG [Mass/volume] in Serum or Plasma

526

3585

1.48

15.54

3.4

2.7

10.37

10.93

g/l

2.00

467

3252

(3019150) Specific gravity of Urine by Refractometry

1559

12716

1.27

14.48

4.7

5.0

1.02

kg/l

0.97

1100

8724

(36660697) Celiac disease serology panel - Serum

478

3246

1.49

14.37

1.2

—

(3023419) Bacteria identified in Sputum by Culture

162

826

1.96

14.30

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

313

1937

1.62

14.27

1.7

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

330

2069

1.60

14.26

1.3

224.12

265.42

u/ml

0.38

294

1889

(3009343) pH of Capillary blood

612

4376

1.42

14.00

3.5

3.8

7.42

1.51

526

3683

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

555

3900

1.44

13.98

3.3

3.7

2.35

2.22

mmol/l

0.32

379

2875

(3028026) IgM [Mass/volume] in Serum or Plasma

424

2827

1.51

13.94

2.4

1.8

1.55

1.37

g/l

0.38

368

2499

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

259

1545

1.68

13.64

1.5

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

624

4499

1.40

13.61

3.5

3.8

5.11

5.18

kpa

1.16

582

4246

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1397

11330

1.27

13.48

3.7

3.5

3.10

2.77

e6/l

0.33

640

5750

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

161

838

1.92

13.40

1.5

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

463

3174

1.47

13.28

1.9

1.8

3.12

2.72

ug/l

0.16

391

2743

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

707

5229

1.37

13.22

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

498

3474

1.45

13.04

2.4

2.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

399

2.32

12.85

1.6

1.4

—

(3039000) Anion gap in Blood by calculation

221

1285

1.72

12.82

5.1

5.9

11.55

11.37

mmol/l

0.31

193

1142

(3018572) Chloride [Moles/volume] in Blood

221

1285

1.72

12.82

5.1

5.9

104.41

104.97

mmol/l

0.90

193

1142

(3033658) Prothrombin time (PT) actual/Normal

1828

15399

1.23

12.45

4.0

4.3

80.49

81.28

0.68

1780

15098

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

413

2.26

12.31

1.6

1.4

—

(3017732) Neutrophils [#/volume] in Blood

779

5915

1.34

12.25

3.0

3.2

4.78

4.86

e9/l

0.23

620

4851

(3034860) Kappa light chains.free [Mass/volume] in Serum

426

2947

1.45

11.67

3.1

2.9

53.08

87.10

mg/l

0.94

312

2493

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

425

2940

1.45

11.65

3.1

2.9

48.82

54.19

mg/l

0.20

310

2491

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

391

2666

1.47

11.54

3.0

2.8

5.09

9.08

ratio

0.38

186

1606

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

549

3995

1.39

11.32

7.3

8.3

15.69

15.59

0.40

520

3854

(3025941) Bacteria identified in Stool by Culture

365

2467

1.49

11.27

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

190

1103

1.72

11.13

1.6

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

869

6793

1.30

11.06

2.5

8.95

10.52

umol/l

1.24

720

5922

(3000492) Spirometry study

500

3601

1.40

10.96

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

203

1210

1.68

10.80

1.3

1.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

852

6671

1.30

10.69

2.8

2.4

65.37

65.54

g/l

0.26

739

5942

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

245

1538

1.59

10.61

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

248

1568

1.58

10.43

1.3

1.2

2.12

0.93

u/ml

0.46

128

(3016750) Collection duration of Urine

360

2.24

10.39

2.4

2.0

493.42

501.95

min

0.26

248

(3013139) Helicobacter pylori Ag [Presence] in Stool

436

3097

1.42

10.36

1.3

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

878

6951

1.28

10.09

1.8

1.9

—

(40768443) Skin Pathology biopsy report

373

2588

1.45

10.09

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

355

2455

1.45

9.78

2.8

2.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1446

12156

1.22

9.69

3.6

3.4

1.02

1.52

e6/l

1.29

700

6613

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

718

5567

1.30

9.68

1.5

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

371

2601

1.43

9.50

2.4

23.05

25.50

au/ml

0.13

142

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

720

5612

1.30

9.32

3.6

101.96

98.15

ng/l

0.43

540

4676

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

463

2.02

9.31

1.6

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

573

4330

1.33

9.27

3.7

2.9

50.99

56.56

ml/min/173m2

4.24

289

1977

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

104

3.24

9.07

1.2

1.3

23.40

31.88

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4096

37764

1.17

9.07

31.9

29.4

329.91

329.68

g/l

0.88

4082

37361

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

444

3238

1.38

9.05

4.1

4.4

1.60

1.53

0.92

418

3070

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1118

9227

1.23

8.90

5.4

5.2

1.03

1.05

mmol/l

1.37

1005

8386

(3042936) Bacteria identified in Isolate by Culture

1077

8864

1.24

8.79

1.9

2.0

—

(3003694) ABO and Rh group [Type] in Blood

1500

12764

1.20

8.76

1.4

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1056

8681

1.24

8.71

3.8

239.86

253.90

u/l

3.30

982

8134

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

4.27

8.68

3.1

2.5

92.32

64.63

mg/l

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

200

1259

1.58

8.64

1.5

1.3

—

(3004451) EKG impression Narrative

434

1.99

8.36

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

585

4507

1.31

8.26

4.9

6.0

24.36

24.53

mmol/l

0.52

550

4307

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

165

2.64

8.23

1.2

72.40

67.04

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

155

931

1.66

8.12

1.5

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

202

1294

1.56

8.11

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

455

1.94

7.99

2.9

3.1

30.47

31.73

mg/l

0.11

354

(40758558) Short blood count panel - Blood

1905

16674

1.17

7.93

5.9

6.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

174

1095

1.58

7.58

1.6

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

1111

1.58

7.57

1.5

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

401

2968

1.35

7.49

4.2

4.5

0.85

0.84

0.21

374

2811

(3009214) Lutropin [Units/volume] in Serum or Plasma

467

1.89

7.43

1.2

1.3

13.16

12.98

u/l

0.04

369

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.85

7.27

2.1

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

118

682

1.72

7.18

1.2

1.5

58.98

64.74

0.70

418

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

366

2697

1.36

7.05

3.4

3.1

4.31

4.28

pmol/l

0.23

308

2329

(3030981) Hyaline casts [#/volume] in Urine by Automated count

678

5433

1.26

7.00

2.8

2.6

0.48

0.58

e6/l

0.76

632

5274

(3021387) Prolactin [Units/volume] in Serum or Plasma

408

1.92

6.94

1.9

293.85

328.13

mu/l

0.68

376

(3037756) Immunofixation for Serum or Plasma

254

1767

1.43

6.88

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

319

2316

1.38

6.76

1.3

63.42

61.85

au/ml

0.04

155

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

114

2.78

6.66

1.0

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

118

701

1.67

6.53

1.3

1.4

—

(3016502) Oxygen saturation in Arterial blood

935

7812

1.21

6.49

5.6

6.5

95.19

94.89

0.80

888

7532

(3019230) Fractional oxyhemoglobin in Venous blood

213

1453

1.46

6.43

2.1

56.14

57.82

0.49

213

1444

(3000570) Elastase.pancreatic [Mass/mass] in Stool

251

1766

1.42

6.41

1.5

1.4

269.78

257.34

ug/g

0.39

148

1104

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1027

0.49

6.37

2.2

2.7

1.19

1.20

mmol/l

1.34

1019

(3017446) Testosterone [Moles/volume] in Serum or Plasma

396

3009

1.32

6.23

2.1

11.33

11.05

nmol/l

0.22

305

2556

(1002224) Polysomnography panel

136

850

1.59

6.18

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

849

7063

1.21

6.16

6.0

7.0

117.59

118.00

g/l

0.24

819

6900

(3041354) Potassium [Moles/volume] in Venous blood

1038

0.50

6.11

2.2

2.6

4.05

4.13

mmol/l

0.87

1030

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

336

1.95

6.10

2.1

1.95

2.71

u/field

0.42

225

(3023323) Follitropin [Units/volume] in Serum or Plasma

264

2.07

5.99

1.4

39.66

32.88

iu/l

0.71

215

(3019977) pH of Arterial blood

1039

8841

1.19

5.89

5.6

6.3

7.42

1.12

568

4789

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

451

1.78

5.70

1.1

—

(3012565) Volume of 24 hour Urine

239

2.07

5.53

1.8

2.3

1744.17

1765.81

0.06

195

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

144

2.41

5.52

1.2

1.1

—

(3003396) Base excess in Arterial blood by calculation

1031

8815

1.18

5.52

5.5

6.2

0.96

0.99

mmol/l

0.10

827

7140

(3045424) Erythrocytes [Presence] in Urine

346

2640

1.31

5.33

2.2

2.1

0.01

0.03

estimate

0.56

105

704

(4035726) Immunohistochemistry procedure

645

5301

1.22

5.30

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

500

1.71

5.24

1.8

8.28

8.25

mmol/l

0.02

500

(3027801) Oxygen [Partial pressure] in Arterial blood

1032

8861

1.18

5.24

5.6

6.3

11.58

11.68

kpa

0.26

973

8423

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1032

8864

1.17

5.22

5.6

6.3

4.97

5.07

kpa

3.26

972

8431

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

707

5883

1.21

5.12

2.5

2.4

40.11

40.08

u/l

0.00

562

4921

(3010838) Calcium [Moles/time] in 24 hour Urine

128

830

1.53

5.03

1.9

1.7

4.27

4.29

mmol/24h

0.03

101

689

(3051387) C reactive protein [Mass/volume] in Capillary blood

192

1351

1.41

4.99

3.6

4.0

30.04

31.25

mg/l

0.18

147

1028

(3042010) Triglyceride [Moles/volume] in Pleural fluid

127

2.42

4.97

1.4

1.2

0.32

2.23

mmol/l

1.77

(3024928) Oxygen saturation in Venous blood

252

1860

1.35

4.91

2.4

55.96

57.37

0.44

240

1759

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

191

1348

1.41

4.89

1.5

0.23

g/l

0.22

179

1268

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

228

1659

1.37

4.87

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

294

1.89

4.81

1.1

1.2

9.93

9.89

mmol/l

0.02

270

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

487

3934

1.24

4.74

1.4

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

275

1.91

4.72

1.3

1.5

16.00

2.50

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

242

1791

1.35

4.65

1.0

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

2134

19409

1.12

4.63

2.6

2.7

—

(3017569) Oxygen content in Arterial blood

489

1.66

4.60

2.4

2.0

15.33

15.71

0.48

489

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

114

2.43

4.57

1.1

1.2

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

808

6876

1.18

4.56

5.4

6.1

1.34

1.42

mmol/l

1.60

786

6695

(1761482) Bacteria [#/volume] in Urine by Culture

137

1949

0.69

4.52

3.7

4.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

236

1751

1.34

4.48

1.8

1.6

9.89

7.81

iu/ml

0.50

393

(3027456) Digoxin [Moles/volume] in Serum or Plasma

314

2436

1.29

4.33

3.5

3.4

0.75

0.82

nmol/l

2.77

262

1973

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

191

1381

1.38

4.29

1.6

1.5

1.15

1.16

g/l

0.29

181

1299

(3024980) IgG subclass 4 [Mass/volume] in Serum

102

654

1.55

4.28

1.9

1.5

0.59

0.90

g/l

3.01

504

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

162

1142

1.41

4.23

1.6

1.7

42.36

3.71

iu/l

0.49

375

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

3.80

4.13

1.1

1.2

2414.86

3226.71

ng/l

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

146

2.17

4.07

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

146

2.17

4.07

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

146

2.17

4.07

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

146

2.17

4.07

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

601

6955

0.84

4.04

7.8

9.0

—

(40768793) Breast Pathology biopsy report

161

1144

1.40

4.04

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

168

1205

1.39

3.99

1.6

1.4

0.36

0.27

mg/l

0.75

470

(4062490) Immunoglobulin typing, IgG

380

1.70

3.98

1.6

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

208

1546

1.34

3.95

1.5

1.6

33.56

33.54

u/ml

0.00

224

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

258

1.84

3.91

1.4

2.46

1.98

u/ml

0.13

159

(3047007) Chlamydophila sp Ab [Presence] in Serum

347

1.71

3.83

1.3

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

876

7609

1.16

3.82

3.7

3.9

11.17

25.41

ug/l

3.19

717

6369

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.22

3.82

1.0

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

369

2973

1.24

3.74

1.5

1.62

1.65

0.26

287

2370

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

238

1820

1.30

3.72

1.9

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

206

1.92

3.72

1.6

1.2

13.18

9.17

umol/l

0.28

138

(3028192) IgG subclass 2 [Mass/volume] in Serum

388

1.66

3.71

1.6

1.2

2.35

2.94

g/l

2.34

280

(3027135) IgG subclass 1 [Mass/volume] in Serum

388

1.66

3.71

1.6

1.2

5.65

7.23

g/l

2.64

280

(3024139) IgG subclass 3 [Mass/volume] in Serum

388

1.66

3.71

1.6

1.2

0.32

0.48

g/l

3.54

281

(3004775) Volume in Urine collected for unspecified duration

519

1.57

3.70

2.6

2.1

662.67

629.60

0.29

324

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

270

2104

1.28

3.65

1.1

104.78

126.43

u/ml

0.38

660

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

308

1.74

3.64

1.1

21.22

33.39

u/l

1.65

253

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

121

836

1.44

3.59

1.2

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

310

1.73

3.57

1.1

73.79

91.40

u/l

1.56

259

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

110

2.25

3.50

1.5

1.3

84.06

364.49

u/l

0.45

(3003329) Lymphocytes/Leukocytes in Synovial fluid

535

1.54

3.48

1.3

1.5

34.71

27.83

0.67

327

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

140

1001

1.39

3.44

1.2

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

111

2.23

3.43

1.3

0.93

1.01

mg/l

0.11

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

251

1957

1.28

3.41

1.9

1.6

38.70

38.80

u/l

0.03

211

1629

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

182

1360

1.33

3.39

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

158

2.00

3.37

1.4

1.2

1.66

1.46

mmol/l

0.52

(40768800) Prostate Pathology biopsy report

186

1399

1.32

3.32

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

488

4094

1.19

3.31

1.4

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

511

4309

1.18

3.27

1.5

—

(4024509) Urine culture

360

2942

1.22

3.23

2.2

2.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

474

1.55

3.22

1.2

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

210

1.84

3.21

4.4

4.9

72.09

72.87

0.07

169

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

484

4076

1.19

3.15

1.9

1.6

1.53

1.57

g/l

0.55

384

3501

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.49

3.14

1.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

777

6793

1.15

3.11

6.0

12.01

12.05

mmol/l

0.04

722

6383

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

527

1.50

3.08

1.7

4.90

4.85

mg/l

0.03

494

(3017704) Immunofixation for Urine

417

1.57

3.06

1.5

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1571

14333

1.11

3.05

4.1

4.3

0.00

0.42

—

216

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

105

2.17

2.99

1.3

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

587

1.47

2.99

1.4

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

113

801

1.40

2.98

2.5

2.2

21.89

26.22

mg/l

0.35

265

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

214

1667

1.28

2.97

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

736

1.41

2.95

1.8

1.9

166.80

2083.42

u/ml

—

(3032773) Endomysium IgG Ab [Titer] in Serum

360

1.60

2.91

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

152

1136

1.33

2.88

1.2

147.00

127.23

titre

0.12

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

175

1335

1.30

2.87

1.6

1.5

0.47

10.97

iu/ml

1.32

327

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

155

1165

1.32

2.83

1.2

1.3

70.37

36.45

u/l

0.78

139

990

(3008295) Osmolality of Serum or Plasma

103

726

1.41

2.82

1.4

1.3

274.60

274.23

mosm/kgh2o

0.06

495

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.19

2.80

1.0

1.5

95.90

79.56

—

(3022621) pH of Urine by Test strip

534

4581

1.16

2.80

3.3

3.4

6.07

6.05

0.20

385

3406

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

123

895

1.36

2.79

1.3

1.4

1767.82

1095.40

e6/l

0.22

107

720

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

435

1.53

2.79

1.1

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

122

887

1.36

2.78

1.3

33.45

26.68

e6/l

0.10

671

(3011544) Albumin [Mass/volume] in Pleural fluid

2.22

2.78

1.1

1.2

17.20

17.14

g/l

0.01

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

214

1684

1.26

2.76

1.4

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

2.16

2.74

1.0

26.70

19.47

u/ml

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

110

790

1.38

2.72

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

360

3004

1.19

2.65

2.8

2.3

1.02

1.04

g/l

0.02

276

2515

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

478

4092

1.16

2.60

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

146

1.90

2.60

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

183

1426

1.27

2.58

2.9

3.0

4353.70

904.79

u/ml

0.40

162

1304

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.15

2.58

1.1

1.3

88.89

80.17

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.61

2.56

1.6

1.8

266.61

404.41

nmol/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

462

1.48

2.52

1.1

27.71

38.21

au/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

423

1.50

2.49

1.3

1.2

91.03

100.65

pmol/l

0.80

423

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.39

2.47

1.1

—

11.40

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

3413

1.17

2.44

2.5

2.2

3.73

3.76

g/l

0.10

346

3035

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

276

1.61

2.43

1.2

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.76

2.43

1.0

1.1

449.63

244.43

nmol/l

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.35

2.39

1.8

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

2.64

2.39

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

3422

1.17

2.37

2.5

2.2

4.09

4.16

g/l

1.05

345

3043

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

402

3424

1.17

2.36

2.5

2.2

7.47

7.59

g/l

0.79

345

3040

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

294

1.58

2.35

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

174

1367

1.26

2.33

1.7

2.0

90.80

88.75

0.60

162

1315

(40768441) Liver Pathology biopsy report

326

1.55

2.33

1.1

1.2

—

(3045414) Leukocytes [Presence] in Urine

620

5459

1.13

2.29

2.4

2.2

0.00

0.01

estimate

1.43

136

914

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.18

2.27

1.2

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

153

1189

1.28

2.25

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

125

946

1.31

2.25

3.5

3.7

889.36

3491.08

iu/ml

0.64

125

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

162

1.77

2.21

1.6

1.4

—

(3011985) Renin [Units/volume] in Plasma

667

1.37

2.21

1.3

1.4

31.92

58.71

mu/l

1.68

594

(3003181) Sodium [Moles/volume] in Urine

194

1556

1.24

2.19

1.4

1.3

60.69

59.69

mmol/l

0.15

159

1256

(3027273) Bicarbonate [Moles/volume] in Venous blood

313

3612

0.85

2.15

2.9

3.4

25.21

25.16

mmol/l

0.08

289

3508

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

142

1.81

2.14

1.2

1.4

0.12

0.15

nmol/l

0.42

(3051101) Glucose [Moles/volume] in Cord blood

147

0.34

2.14

4.4

5.9

11.06

8.83

mmol/l

—

147

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

187

1499

1.24

2.13

2.0

2.1

3.60

3.66

g/l

0.23

178

1423

(3034770) Mitochondria Ab [Titer] in Serum

149

1164

1.27

2.12

1.2

1.1

1201.43

968.48

titre

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

513

1.41

2.12

1.2

2.04

3.38

u/ml

0.85

169

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

433

3744

1.15

2.11

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

134

1034

1.28

2.11

1.3

702.40

587.20

mg/l

0.30

129

977

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

192

1546

1.23

2.11

2.6

2.2

99.89

99.50

ug/min

0.01

119

883

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

375

3209

1.16

2.10

2.5

2.3

2.97

3.03

g/l

0.55

319

2824

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

651

1.35

2.05

1.1

1.2

47.64

64.68

u/l

3.75

554

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

225

1848

1.21

2.04

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

225

1848

1.21

2.04

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

355

3036

1.16

2.02

2.5

2.2

10.14

10.37

g/l

0.40

295

2615

(3039162) Centromere protein B Ab [Units/volume] in Serum

529

1.39

1.97

1.4

1.2

22.46

50.05

u/ml

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

741

1.32

1.97

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

165

1319

1.24

1.96

1.8

2.2

206.61

218.45

0.94

150

1236

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

623

1.35

1.95

1.2

253.17

248.77

pmol/l

0.06

508

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

285

1.53

1.95

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

125

1.82

1.94

1.7

1.4

74.98

314.62

nmol/24h

1.37

125

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

147

1.75

1.94

1.1

1.2

1.07

1.08

ratio

0.09

112

(3043410) Blood group antigens tested for on Red Blood Cells

177

1.68

1.93

1.6

1.9

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

440

1.42

1.92

1.1

122.38

112.35

1.35

382

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.49

1.92

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

132

1032

1.27

1.91

1.2

1.3

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

678

1.33

1.88

1.9

1.7

29.00

26.22

u/ml

0.21

151

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.92

1.88

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

174

1407

1.23

1.87

1.5

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

298

2535

1.17

1.84

2.7

2.2

0.02

0.04

g/l

0.66

249

2252

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

297

1.50

1.84

1.6

1.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

630

1.34

1.83

1.4

1.3

—

(4195642) Thrombophilia screening test

437

1.40

1.82

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.12

1.80

3.0

2.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

356

1.45

1.79

1.2

1.1

94.13

90.63

0.48

322

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

348

3918

0.87

1.77

3.3

4.1

42.21

45.47

1.65

339

3865

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

456

1.39

1.77

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

720

1.31

1.76

1.3

12.83

13.21

u/l

0.08

658

(3008898) HLA-B27 [Presence]

661

1.32

1.75

1.0

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

175

1.64

1.74

1.2

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

441

1.39

1.74

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

303

1.47

1.70

1.1

2.12

14.84

nmol/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

255

1.51

1.69

1.1

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

287

2460

1.16

1.64

2.7

2.2

0.00

g/l

0.79

236

2140

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.89

1.64

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.55

1.63

1.0

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

107

835

1.27

1.62

1.3

1.2

50.68

54.08

u/ml

0.07

100

(3026250) Tacrolimus [Mass/volume] in Blood

104

1.81

1.61

34.7

34.4

6.15

6.93

ug/l

1.14

(3001019) Free T4 and TSH panel - Serum or Plasma

465

1.36

1.60

1.7

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.07

1.60

2.1

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

219

1.54

1.59

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

219

1.54

1.59

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.59

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.91

1.58

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

698

1.29

1.58

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

578

1.32

1.57

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

236

1.51

1.56

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

245

1.49

1.54

1.8

2.3

9.87

9.78

kpa

0.09

245

(40762887) Creatinine [Moles/volume] in Blood

2.25

1.53

2.5

1.6

—

(1617658) Protocol used for examination of sentinel lymph nodes

360

1.40

1.53

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

246

1.49

1.51

1.8

2.3

4.86

4.94

kpa

0.14

246

(3036489) Thrombin time

228

1935

1.17

1.51

1.6

1.8

20.97

21.69

1.84

203

1783

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

314

2732

1.14

1.49

2.0

2.2

451.56

697.42

ug/l

1.40

294

2596

(4211845) Urine protein measurement

296

1.44

1.48

6.3

3.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

280

1.45

1.47

1.5

1.3

1.43

1.19

nmol/l

0.37

202

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

100

1.78

1.47

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

248

1.48

1.46

1.2

—

(3034092) Cytoplasmic Ig cells/cells in Blood

2.13

1.46

11.5

14.8

0.35

0.23

0.35

(40761535) Cells panel - Urine sediment

450

4916

0.90

1.45

3.1

3.7

—

1.00

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

249

1.47

1.44

1.2

—

(3006462) Nitrate [Presence] in Urine

274

1.44

1.42

6.5

3.7

—

(3000330) Specific gravity of Urine by Test strip

324

3602

0.88

1.42

3.5

4.0

1.02

ratio

1.67

301

3231

(3028308) Erythrocytes [#/volume] in Pleural fluid

1160

0.80

1.40

1.3

1.4

70755.60

52641.52

e6/l

0.16

670

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

384

1.37

1.39

1.1

—

126.00

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

384

1.37

1.39

1.1

215.00

135.07

titre

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.22

1.38

1.3

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

148

1.60

1.37

1.6

0.24

0.36

ug/l

1.85

(3035880) pH of Pleural fluid

522

1.31

1.36

1.4

1.3

7.42

0.02

357

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

127

1034

1.22

1.36

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

164

1.57

1.36

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

196

1.51

1.35

1.5

68.75

73.40

umol/l

0.09

113

(3025549) Creatine [Moles/time] in 24 hour Urine

2.17

1.35

1.8

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.91

1.34

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

646

1.27

1.33

1.5

1.4

15.25

13.53

u/l

1.36

622

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

111

1.69

1.33

1.1

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

155

1290

1.19

1.33

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

788

1.24

1.32

3.5

3.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

119

1.66

1.31

2.1

1.5

1.17

1.20

mmol/l

0.92

113

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.40

1.30

1.1

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

441

1.32

1.28

1.8

1.7

182.74

191.60

pmol/l

0.30

393

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

729

1.25

1.28

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

207

1.48

1.28

1.2

1.1

49.07

47.33

mg/l

0.07

176

(44813793) Dust mix specific IgE antibody measurement

199

1.49

1.27

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

200

1.48

1.25

1.7

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

1.61

1.24

1.0

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

279

2444

1.13

1.24

1.2

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

300

2640

1.13

1.24

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.91

1.23

1.1

1.7

—

(3016038) Potassium [Moles/volume] in Urine

531

1.29

1.23

1.2

1.1

34.58

34.95

mmol/l

0.05

438

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

575

1.27

1.23

1.2

1.1

271.53

293.57

u/ml

0.27

347

(44806118) Parainfluenza type 4 nucleic acid detection

672

1.25

1.22

1.4

1.3

—

(44790047) Parainfluenza type 1 nucleic acid detection

672

1.25

1.22

1.4

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

672

1.25

1.22

1.4

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

672

1.25

1.22

1.4

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.76

1.22

3.1

3.0

0.33

0.54

u/field

0.56

(3014271) Vancomycin [Susceptibility]

471

1.30

1.22

2.9

3.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

631

1.25

1.18

1.4

1.3

175.25

160.19

au/ml

0.72

195

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

244

2128

1.14

1.17

1.2

1.3

—

(21494814) CD8 cells/Lymphocytes in Specimen

171

1.50

1.17

1.7

1.9

31.08

30.05

0.10

171

(3001893) Eosinophils/Leukocytes in Pleural fluid

295

1.37

1.16

1.4

1.5

2.78

3.00

0.09

243

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

237

1.42

1.15

1.1

—

80.63

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

409

3682

1.10

1.14

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

213

1.44

1.13

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.47

1.13

1.4

2.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.91

1.13

1.2

6.16

6.41

mmol/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

620

6578

0.92

1.12

2.2

2.5

5.61

6.59

ug/l

1.18

492

5529

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

504

1.28

1.12

1.2

2.30

4.96

u/ml

2.21

237

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

654

1.24

1.12

2.3

2.4

2.15

1.75

u/field

0.19

351

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

357

1.33

1.11

1.1

—

4.75

—

(4268621) Lupus anticoagulant assay

340

1.34

1.11

2.4

2.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

134

1124

1.18

1.10

1.2

1.3

83.08

309.20

titre

3.00

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

567

1.26

1.10

1.3

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

126

1.57

1.09

1.7

2.4

6165.95

67.63

ug/l

0.59

126

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.87

1.08

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

1.60

1.07

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.76

1.06

1.1

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

151

1.51

1.06

1.1

1.3

41.43

30.36

0.50

101

(4027681) Cerebrospinal fluid IgG ratio and IgG index

135

1.54

1.06

1.2

0.93

0.50

ratio

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

537

0.75

1.04

1.1

56.00

498.09

iu/ml

—

(3045142) Bone marrow Pathology biopsy report

724

1.22

1.03

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

556

1.25

1.01

1.1

1.49

1.60

g/l

1.74

505

(3016650) Hepatitis A virus Ab [Presence] in Serum

645

1.23

1.01

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.77

1.00

1.3

1.2

13.33

15.60

mm/h

0.32

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.77

1.00

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

194

1.43

1.00

1.1

294.87

311.78

mg/l

0.23

171

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

178

1.44

0.99

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

443

1.27

0.99

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

595

6285

0.93

0.98

5.4

5.3

35.40

34.09

1.71

288

3823

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

279

1.35

0.98

1.2

1.3

497.97

283.48

ug/l

0.22

149

(3036525) Urea [Moles/time] in 24 hour Urine

1.98

0.98

2.9

3.6

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

154

1.48

0.98

1.3

1.6

5.71

8.42

0.42

(3008116) Ketones [Moles/volume] in Urine by Test strip

146

1.49

0.98

1.6

1.5

0.18

0.36

mmol/l

—

(21494815) CD4 cells/Lymphocytes in Specimen

323

1.32

0.96

1.5

1.9

40.03

37.67

0.33

312

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

721

1.21

0.96

1.3

1.2

—

21.16

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

375

1.29

0.96

2.5

2.2

107.44

85.24

ug/min

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

261

2321

1.11

0.96

2.8

2.2

0.00

g/l

-0.00

236

2133

(3023430) Cat dander IgE Ab [Units/volume] in Serum

139

1.49

0.95

1.0

1.1

0.71

1.06

u/ml

0.29

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

247

1.36

0.95

6.3

6.0

12.55

227.18

ug/l

0.94

148

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

411

1.28

0.95

1.7

107.01

112.57

ng/l

0.20

411

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

368

1.29

0.94

1.3

1.5

12.21

6.33

u/l

1.04

284

(3011412) CD3 cells [#/volume] in Blood

377

1.29

0.93

1.5

1.9

1074.41

960.59

e6/l

0.35

340

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

136

1162

1.16

0.93

1.3

1.2

24.08

3.23

u/ml

0.54

116

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.20

0.92

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

887

0.82

0.92

1.3

0.90

0.84

nmol/l

0.18

724

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.87

0.92

7.4

4.9

—

(3025577) Chromium [Mass/volume] in Blood

458

1.25

0.90

2.2

2.1

2.36

2.11

ug/l

0.29

383

(21494890) Protein electrophoresis panel - 24 hour Urine

782

1.19

0.89

1.9

1.8

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

101

1.57

0.89

8.4

8.2

14.14

13.73

0.49

101

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

487

4480

1.08

0.88

3.4

3.5

23.98

24.20

mmol/l

0.84

478

4389

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

281

2523

1.10

0.88

1.8

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

136

1168

1.15

0.88

1.3

1.2

4.96

4.93

u/ml

0.00

174

(40765096) Chromosome analysis panel by Banding

167

0.59

0.88

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

238

2119

1.11

0.88

3.3

3.7

1.88

1.86

index

0.01

110

1109

(3023183) Ammonium ion [Moles/volume] in Plasma

150

1299

1.14

0.87

2.1

2.0

27.86

33.34

umol/l

2.49

119

1097

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

604

1.21

0.86

1.3

0.20

0.21

nmol/l

0.10

484

(3034988) Calcium [Moles/volume] in Capillary blood

126

1.49

0.86

2.1

1.5

1.16

1.18

mmol/l

0.64

120

(3005532) Lymphocytes/Leukocytes in Pleural fluid

347

1.28

0.86

1.3

1.5

72.13

67.18

0.50

277

(3035637) Corticotropin [Mass/volume] in Plasma

596

1.21

0.85

1.6

1.5

58.89

31.54

ng/l

0.36

596

(40768446) Kidney Pathology biopsy report

143

1.45

0.85

1.7

1.4

—

(3006270) Folate [Moles/volume] in Blood

579

1.21

0.84

1.3

1.2

288.73

328.23

nmol/l

1.08

428

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

144

1248

1.14

0.83

2.0

1.7

12.88

mg/l

0.00

131

1133

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.91

0.83

2.2

1.7

21.12

16.41

umol/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.91

0.83

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

103

1.54

0.83

1.1

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

110

0.54

0.83

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

672

1.19

0.81

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.72

0.81

1.0

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

502

1.22

0.80

1.3

1.2

1.77

1.46

nmol/l

1.05

441

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.79

0.0

1.1

—

6.32

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

282

1.30

0.78

1.2

1.1

0.45

0.81

u/ml

0.79

151

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

119

1024

1.15

0.78

1.3

1.2

13.84

3.56

u/ml

0.69

(3019420) Tryptase [Mass/volume] in Serum or Plasma

188

1.37

0.77

1.6

8.78

13.88

ug/l

0.54

170

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

188

1.37

0.77

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

122

0.57

0.77

1.1

1.0

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.77

0.0

13.6

—

201.52

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

425

1.23

0.76

2.4

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

363

1.25

0.75

1.2

8.36

7.98

mmol/l

0.29

290

(3022493) Free Hemoglobin [Mass/volume] in Plasma

284

1.29

0.75

1.2

2.9

62.50

62.13

mg/l

0.01

197

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.06

0.74

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.06

0.74

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.06

0.74

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

140

1225

1.13

0.73

1.3

1.2

59.80

49.04

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

175

1553

1.12

0.72

1.6

1.5

14705.88

15359.08

e6/l

0.08

120

1047

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

582

1.19

0.71

1.5

1.3

201.00

375.30

titre

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

402

1.23

0.71

1.1

1.2

93.98

104.97

u/l

0.32

335

(3033923) Metanephrine [Moles/time] in 24 hour Urine

108

1.46

0.69

1.0

1.1

0.61

0.65

umol/24h

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.65

0.69

1.0

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

395

1.23

0.68

1.1

1.2

26.69

30.61

u/l

0.26

319

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

297

2714

1.08

0.68

2.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.65

0.67

1.0

—

(3022689) Creatine [Moles/volume] in Urine

134

1.40

0.67

1.2

1.3

6.45

6.82

mmol/l

0.17

134

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

550

1.19

0.67

1.3

—

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

246

1.29

0.66

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

502

4684

1.06

0.65

6.8

7.6

24.34

24.33

mmol/l

0.02

480

4496

(3002032) Base excess in Venous blood by calculation

754

7785

0.95

0.65

3.3

3.5

1.48

1.89

mmol/l

2.20

651

6737

(3042733) HLA Ab [Presence] in Serum

1.62

0.65

4.0

4.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.51

0.65

1.1

1.3

1.42

2.11

umol/l

0.87

(3038177) Helicobacter pylori Ab [Presence] in Serum

507

1.19

0.64

1.2

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

782

1.15

0.64

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.57

0.64

1.1

1.2

11.57

10.93

u/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

204

1.31

0.64

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

399

1.21

0.64

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

144

1.37

0.63

1.1

2.16

1.15

u/ml

0.38

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.70

0.63

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

196

1.31

0.63

1.5

1.6

90.84

122.71

ug/l

0.84

167

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

209

0.71

0.62

1.5

1.4

1.55

1.53

g/l

0.17

209

(3023199) Leukocytes [#/volume] in Pleural fluid

115

1278

0.89

0.62

1.3

1.5

1185.24

2439.72

e6/l

1.02

883

(3026051) Granulocytes/Leukocytes in Pleural fluid

197

1.30

0.61

1.4

19.14

22.02

0.27

157

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

1.40

0.60

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

396

0.80

0.60

2.2

2.6

6.88

7.27

mmol/l

0.66

285

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

321

1.23

0.60

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

180

1.32

0.60

1.1

1.2

128.96

154.41

mmol/24h

1.21

180

(3003740) Influenza virus B Ag [Presence] in Specimen

250

1.27

0.60

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.2

—

318.45

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

340

1.22

0.59

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

155

1.34

0.59

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

1021

0.88

0.58

1.5

1.8

17.53

24.29

ug/l

1.93

991

(3029075) Extractable nuclear Ab panel - Serum

251

0.75

0.58

1.2

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.74

0.58

1.0

—

(3023410) Appearance of Cerebral spinal fluid

403

0.81

0.56

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

700

1.14

0.55

1.4

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

126

1120

1.11

0.55

4.3

3.7

1.05

1.59

1.87

107

972

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

516

1.17

0.55

1.3

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

380

1.20

0.54

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

335

1.21

0.54

1.2

1.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

317

1.22

0.54

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

149

1.33

0.54

1.5

1.3

122.36

155.92

nmol/l

0.36

101

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

336

1.21

0.53

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

268

0.77

0.52

1.0

296.69

297.51

mg/l

0.02

240

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

565

1.15

0.52

1.6

1.3

61.67

62.11

titre

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.43

0.52

2.0

1.5

—

(3020876) Protein [Mass/time] in 24 hour Urine

102

900

1.12

0.52

2.3

2.2

0.89

0.97

g/24h

0.16

494

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

520

1.16

0.51

1.3

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.40

0.51

1.0

80.43

92.31

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.41

0.50

6.8

9.3

5.88

5.84

kpa

0.02

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

330

1.20

0.49

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

285

1.21

0.49

1.3

1.2

1.30

0.90

promille

0.80

219

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

349

1.19

0.48

1.2

1.1

—

(4281824) Cell count and differential, peritoneal fluid

617

0.86

0.48

1.1

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.40

0.47

1.8

1.6

10.43

9.85

ug/l

0.17

(42529406) Shigella sp [Presence] in Stool by Culture

145

1559

0.92

0.47

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

145

1558

0.92

0.46

1.2

—

(4212803) Bone marrow aspirate examination

0.59

0.45

1.2

1.1

—

(21494755) Public health laboratory ask at order entry panel

508

0.85

0.45

1.6

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

1.41

0.45

1.1

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.33

0.45

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

325

1.19

0.44

6.1

5.2

204.31

113.02

u/ml

0.28

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.38

0.44

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.37

0.43

1.0

1.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

120

1.32

0.43

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

120

1.32

0.43

1.1

—

5.71

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

483

1.15

0.43

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

391

1.16

0.42

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

391

1.16

0.42

1.4

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

901

0.90

0.42

3.2

3.7

22.85

50.41

u/ml

4.65

869

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.54

0.42

1.2

1.1

—

2.70

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

312

0.82

0.41

7.5

3.0

0.92

1.15

0.34

312

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.41

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

192

1.24

0.41

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

1.50

0.41

1.0

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

1.50

0.41

1.4

1.5

—

78.58

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

159

0.74

0.41

1.6

1.3

—

(3019225) pH of Specimen

588

6019

0.96

0.40

4.3

4.8

7.38

7.37

2.83

344

4286

(40763791) Oxygen content in Venous blood by calculation

0.00

0.40

0.0

2.1

—

12.28

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.40

0.0

1.1

—

455.40

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.6

—

28.96

—

(21494434) Karyotype in Bone marrow

607

1.12

0.40

1.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

100

899

1.10

0.40

5.2

5.9

12.34

12.76

mg/l

0.40

805

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

202

1.22

0.39

1.2

8.66

11.72

pmol/l

—

(3020650) Glucose [Presence] in Urine

158

0.75

0.39

1.9

1.8

0.00

0.02

estimate

0.50

158

(3011335) Digoxin [Mass/volume] in Serum or Plasma

103

0.67

0.39

3.0

2.4

0.76

0.67

ug/l

—

103

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

145

1543

0.93

0.39

1.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

194

1.22

0.38

1.1

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.33

0.37

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

308

0.83

0.37

2.0

2.2

14.68

31.10

umol/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

519

0.87

0.37

1.4

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

492

4679

1.04

0.37

2.7

3.1

124.51

125.77

g/l

0.64

471

4559

(3034426) Prothrombin time (PT)

106

1.30

0.36

1.0

1.3

28.71

28.51

0.07

106

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

285

0.83

0.36

1.1

1.7

37.22

39.19

g/l

0.76

285

(3028679) Herpes simplex virus Ab [Presence] in Serum

142

1.25

0.35

1.1

—

(4015189) Microbial culture of sputum

142

1.25

0.35

2.4

2.0

—

(3047189) Immunofixation for 24 hour Urine

352

1.15

0.35

1.6

—

(3000991) Gas panel - Venous blood

692

6634

1.03

0.35

6.8

7.1

—

(3037121) Protein [Mass/volume] in Urine

233

2181

1.06

0.34

2.9

530.83

369.57

mg/l

0.26

913

(4133840) Spirometry

1.37

0.34

1.5

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.35

0.34

1.0

1.1

1.63

1.70

umol/24h

—

(3024263) Appearance of Synovial fluid

325

0.85

0.33

2.4

1.5

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.32

0.33

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

314

0.85

0.33

1.1

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

142

0.76

0.33

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

171

1.21

0.32

1.1

0.11

0.34

u/ml

1.05

(37208534) Antinuclear antibody arbitrary concentration in serum

135

1.24

0.32

1.2

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

235

1.18

0.32

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1518

14733

1.02

0.32

2.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

225

2333

0.95

0.30

3.2

4.2

94.32

102.85

u/ml

0.08

213

2226

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

200

1.19

0.30

2.5

2.3

0.62

0.63

mmol/l

0.21

200

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

405

0.88

0.30

1.1

1.2

210.40

184.61

miu/ml

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

237

1.17

0.30

1.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

550

0.90

0.29

1.4

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

310

0.86

0.29

1.3

1.8

104.93

97.80

umol/l

0.17

310

(3004716) Salmonella sp identified in Stool by Organism specific culture

167

1743

0.94

0.29

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

623

1.09

0.28

2.1

3.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

256

0.85

0.28

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

102

1.26

0.27

1.0

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

291

2988

0.96

0.27

2.5

2.6

0.37

0.35

iu/ml

0.32

155

1654

(3003888) Timothy IgE Ab [Units/volume] in Serum

230

1.16

0.27

1.1

1.0

0.24

1.55

u/ml

2.91

(3017354) Segmented neutrophils/Leukocytes in Blood

700

0.92

0.27

4.0

3.8

57.17

58.86

0.19

575

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

275

2609

1.04

0.27

3.4

3.0

3062.58

3034.22

u/ml

0.00

245

2205

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

380

1.12

0.26

1.0

33.34

44.25

ng/l

1.67

229

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

380

1.12

0.26

1.0

299.40

329.32

ng/l

0.40

234

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.20

0.26

6.5

7.6

9.30

10.26

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.20

0.26

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

381

1.12

0.26

1.0

769.24

675.55

ng/l

0.57

228

(40768795) Lymph node Pathology biopsy report

552

1.09

0.25

1.3

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

104

1.23

0.24

1.3

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

479

1.09

0.23

2.9

3.1

61.50

32.86

mg/l

0.51

358

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

478

0.91

0.23

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

478

0.91

0.23

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

478

0.91

0.23

1.4

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

160

1.17

0.22

1.4

18.82

16.56

pmol/l

0.54

125

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.75

0.22

14.0

4.5

33.29

60.85

u/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

0.80

0.22

1.1

1330.40

1754.98

miu/ml

—

123

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.23

0.22

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.20

0.21

1.2

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

226

1.14

0.21

1.1

1.0

0.18

1.45

u/ml

1.55

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.4

—

346.90

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

31.73

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.21

0.0

1.4

—

19.47

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

2340.91

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3044927) Protein electrophoresis panel - Urine

807

1.07

0.21

1.1

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.20

0.0

1.4

—

(40757373) Influenza virus identified in Isolate

162

1.16

0.20

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

349

0.90

0.19

1.7

2.3

—

(3013727) Leukocytes other/Leukocytes in Blood

225

0.88

0.19

8.5

3.4

51.03

55.14

0.26

217

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

847

0.94

0.18

2.0

1.8

2.99

3.16

mmol/l

0.76

619

(44806420) Estimation of glomerular filtration rate

317

0.90

0.18

2.2

2.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

203

0.88

0.17

1.6

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

203

0.88

0.17

1.6

1.8

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.21

0.17

1.2

1.3

11.85

7.74

mg/l

0.50

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

119

0.83

0.17

1.0

1.3

78.40

112.12

ug/l

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

243

0.89

0.16

1.0

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

156

1.14

0.16

1.6

1.8

213.50

326.18

mu/l

1.80

117

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.13

0.16

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

701

1.06

0.16

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

559

0.94

0.16

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

194

1.12

0.16

1.1

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

232

1.11

0.15

1.3

1.9

525.05

455.06

e6/l

0.19

194

(37021550) Renin [Units/volume] in Plasma --upright

110

1.17

0.15

1.4

1.3

29.66

72.22

mu/l

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

214

1.11

0.14

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

151

1441

1.04

0.14

1.4

1.5

30.83

30.61

g/l

0.08

134

1275

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

471

4733

0.98

0.14

7.3

8.0

0.61

0.63

0.66

466

4698

(3009466) Valproate [Moles/volume] in Serum or Plasma

695

1.05

0.14

4.3

3.8

317.55

320.85

umol/l

0.06

572

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

189

0.89

0.14

1.9

2.1

51.73

53.05

umol/l

0.04

156

(40768806) Pleura Pathology biopsy report

106

1089

0.96

0.14

1.6

—

(3044007) Cell count panel - Peritoneal fluid

215

1.10

0.13

1.5

1.8

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

215

1.10

0.13

1.4

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

372

0.93

0.13

1.1

—

75.28

—

(3014891) Appearance of Pleural fluid

187

1.11

0.13

1.5

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

121

1.14

0.13

1.1

1.2

321.43

245.03

pmol/l

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

717

1.05

0.12

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.17

0.12

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

146

0.88

0.12

1.5

1.4

—

(3028433) Virus identified in Specimen by Culture

156

0.89

0.12

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

108

1031

1.03

0.11

1.3

1.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

298

0.93

0.11

1.1

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

205

0.91

0.10

1.5

1.8

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.15

0.10

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

200

1.09

0.10

1.3

1.2

47.70

39.36

g/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

723

1.04

0.10

1.3

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

128

1230

1.03

0.09

2.0

3.26

3.20

ratio

0.17

103

1006

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.10

0.09

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.05

0.09

1.8

1.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

559

1.04

0.09

1.4

269471.20

184447.19

e6/l

0.22

362

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

108

1097

0.97

0.09

1.2

—

(3048879) Bone marrow aspiration report

201

1.08

0.09

1.2

1.5

—

2.00

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.12

0.09

1.3

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

335

0.94

0.09

1.1

5.93

2.93

eliau/ml

—

(3022313) Gas panel - Capillary blood

294

2948

0.98

0.09

3.8

4.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

227

2202

1.02

0.08

4.0

4.2

24.61

24.98

mmol/l

0.98

190

1943

(3008757) Leukocyte morphology finding [Identifier] in Blood

636

0.96

0.08

5.3

4.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.02

0.08

2.5

3.2

1.68

1.24

mg/l

—

(3024932) HLA-DR beta [Type]

0.82

0.08

1.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.77

0.08

1.0

1.2

64.00

61.95

ug/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

106

1.12

0.08

13.0

13.9

4.87

5.14

mmol/l

0.16

106

(3024354) Oxygen [Partial pressure] in Venous blood

669

6664

0.99

0.08

2.5

3.0

4.15

4.31

kpa

1.61

646

6459

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.05

0.08

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.08

0.07

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

126

1.10

0.07

1.4

1.3

—

(3012544) pH of Venous blood

808

8034

0.99

0.07

3.2

3.5

7.38

0.18

386

4804

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

242

1.06

0.07

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

107

1.11

0.07

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

422

0.96

0.06

1.9

1.6

—

(4034850) Laboratory test

166

1611

1.02

0.06

9.1

13.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

740

1.03

0.06

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

117

1.10

0.06

2.3

1.3

160.53

156.14

pmol/l

0.04

117

(3002619) Bacteria identified in Specimen by Culture

170

0.93

0.06

1.4

1.3

—

(3033099) Centromere Ab [Titer] in Serum

1.11

0.05

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

149

0.93

0.05

1.5

1.4

—

(3027008) Opiates [Presence] in Urine

148

0.93

0.04

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

258

0.96

0.04

1.8

2.5

38.79

35.80

0.31

144

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

218

0.95

0.04

1.5

1.6

45822.13

25159.32

e6/l

—

117

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

403

1.03

0.03

2.2

2.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

698

1.02

0.03

1.3

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

757

1.02

0.03

3.7

3.5

13.87

12.55

index

0.26

397

(3023487) Leukocytes [#/volume] in Peritoneal fluid

246

0.96

0.02

1.5

1.8

780.00

3406.86

e6/l

0.66

163

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

166

0.95

0.02

1.6

1.3

27.94

29.11

umol/l

0.21

152

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

701

1.01

0.02

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

701

1.01

0.02

1.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

284

0.97

0.01

1.4

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

284

0.97

0.01

1.4

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

284

0.97

0.01

1.4

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

284

0.97

0.01

1.4

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

1.06

0.00

1.7

1.4

—

(3016879) Cocaine [Presence] in Urine

144

0.96

0.00

1.5

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

144

0.96

0.00

1.4

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

261

1.02

0.00

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

271

1.02

0.00

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

143

0.97

0.00

1.5

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

143

0.97

0.00

1.4

2.0

—

(3032057) Clostridioides difficile [Presence] in Stool

173

1.03

0.00

2.0

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

365

1.00

0.00

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

127

1.01

0.00

1.2

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

142

0.97

0.00

1.1

1.4

1.18

mmol/l

0.04

142

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

790

1.00

0.00

1.9

1.7

4.35

5.01

mg/l

0.17

621

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

346

1.00

0.00

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

346

1.00

0.00

1.3

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

153

1.03

0.00

2.3

2.4

6.35

7.73

mmol/l

2.97

108

(4146454) Self-monitoring of blood glucose

696

0.99

0.00

2.5

2.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

176

1.01

0.00

2.1

1.8

19.89

52.78

u/l

1.38

163

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

107

1.02

0.00

1.1

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

107

1.02

0.00

1.6

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

810

7994

1.00

0.00

3.2

3.5

5.84

kpa

0.04

783

7773

(3025130) Human papilloma virus identified in Specimen

296

1.00

0.00

1.5

1.7

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.91

-0.00

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

1.70

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

362.20

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.99

-0.00

1.3

1.7

40.87

46.17

umol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.8

—

2.85

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.7

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

9.09

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.25

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.96

-0.00

1.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

0.20

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.93

-0.00

1.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_PRESBY and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_HL_PRESBY	0.901 [0.83, 0.98]	0.013
Birth year	0.994 [0.99, 1.0]	0.113

During the follow-up period (1.1.1998 — 31.12.2019), 17982 out of 34767 females with H8_HL_PRESBY died.

Males

Parameter	HR [95% CI]	p-value
H8_HL_PRESBY	0.939 [0.85, 1.03]	0.19
Birth year	0.987 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 12373 out of 23536 males with H8_HL_PRESBY died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_PRESBY.

N-year risk	Females	Males
1	0.082%	0.164%
5	0.533%	1.051%
10	1.268%	2.716%
15	2.457%	5.224%
20	4.262%	8.789%

Relationships between endpoints

↥

Index endpoint: H8_HL_PRESBY – Presbycusis

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Presbycusis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints